[go: up one dir, main page]

TWI221772B - Chicken egg anti-inflammatory composition in partially purified form - Google Patents

Chicken egg anti-inflammatory composition in partially purified form Download PDF

Info

Publication number
TWI221772B
TWI221772B TW86112945A TW86112945A TWI221772B TW I221772 B TWI221772 B TW I221772B TW 86112945 A TW86112945 A TW 86112945A TW 86112945 A TW86112945 A TW 86112945A TW I221772 B TWI221772 B TW I221772B
Authority
TW
Taiwan
Prior art keywords
egg
inflammatory
eggs
arthritis
hyperimmune
Prior art date
Application number
TW86112945A
Other languages
Chinese (zh)
Inventor
Sandra Fitzpatrick-Mcelligott
Jeffrey G Hunchar
Young-Zoon Lee
Lee R Beck
Original Assignee
Dcv Biolog Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dcv Biolog Lp filed Critical Dcv Biolog Lp
Application granted granted Critical
Publication of TWI221772B publication Critical patent/TWI221772B/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention is directed to a composition and method for the treatment and prevention of inflammation in general. The composition is an egg product obtained from an avian which has been hyperimmunized with no immungenic mixture. The invention is further directed to an anti-inflammatory composition which has been partially purified from a hyperimmunized egg. The partially purified anti-inflammatory composition, when administered to a subject animal is effective in treating and preventing inflammation.

Description

1221772 A7 五、發明説明(1 ) 本發明概括地有關治療和預防發炎之組合物與方法,本 發明特別係有關即源抗發炎組合物,其經部份純化形式之 製法及其在治療發炎(特別是關節炎),和自體免疫疾病上之 用途。 發炎 發炎,如 DodaruTs MecUcal Dictionary 中所定義者,為,,一 種局部保護性反應,係由組織傷害或破壞所謗發,其用以 破壞,減弱或堵塞傷害劑和受傷組織”。其特徵在於微血管 穿孔,血液成份滲入間質空隙,及白血球移動到發炎組織 内。於巨觀看來,其通常伴隨著發紅,水腫,痛覺過敏(柔 嫩),和痛苦。 於此種複雜的反應中,會局部釋放出化學媒介劑,例如 組織胺,5-羥基色胺,各種趨化性組合物,缓激肽,白三 烯素,和前列腺素。吞噬性細胞會移動到該區域,且細胞 A S學體膜可能破裂,釋出胞溶性酵素。 源自類風濕性關節炎的發炎大致上相關抗原與抗體補體 4聯合,其促成會吸引白血球的趨化性與化學活化性組合 物I局部釋出。白血球會呑噬抗原一抗體與補體形成之複 口物,且也會釋出包含在溶酶體内的許多種酵素,彼等溶 酶體酵素隨後會促成對軟骨和其它組織之傷害,且此舉更 增進發炎程度。此外也可能涉及經細胞媒介的免疫反應。 於此過程中也會f睪出前列腺素,纟為細胞功能的主要細胞 内調節劑。 請 先 閲 讀 背 1¾ 5 i 事 項1221772 A7 V. Description of the invention (1) The present invention relates generally to compositions and methods for the treatment and prevention of inflammation, and the present invention is particularly related to an immediate-source anti-inflammatory composition, a method of preparing it in a partially purified form, and its use in treating inflammation ( Especially arthritis), and autoimmune diseases. Inflammation, as defined in the DodaruTs MecUcal Dictionary, is a local protective response that is stigmatized by tissue injury or destruction, which is used to destroy, weaken or block injury agents and injured tissue. "It is characterized by microvessels Perforation, blood components penetrate into the interstitial space, and white blood cells move into the inflamed tissue. When viewed from the giant, it is usually accompanied by redness, edema, hyperalgesia (softness), and pain. In this complex reaction, it is local Chemical mediators are released, such as histamine, 5-hydroxytryptamine, various chemotactic compositions, bradykinin, leukotrienes, and prostaglandins. Phagocytic cells will move to this area and the cell AS The membrane may rupture and release cytolytic enzymes. Inflammation derived from rheumatoid arthritis is generally associated with antibody complement 4, which promotes the local release of chemotactic and chemically active composition I, which attracts white blood cells. White blood cells Will chew the complex formed by antigen-antibody and complement, and also release many enzymes contained in lysosomes. Will promote damage to cartilage and other tissues, and this will increase the degree of inflammation. In addition, it may also involve the immune response through the cell-mediated. In this process, prostaglandins are also produced, which is the main intracellular regulation of cell functions. Please read back 1¾ 5 i matters first

i 經濟部中央標準局員工消費合作社印製 -4 - 1221772 A7i Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economy -4-1221772 A7

發災反應為有上文所定義的發炎特徵之任何反應。為今 於醫學技藝人士所熟知者為發炎反應會引起與不同疾病2 傷害相關聯的許多身體不適(即,疼痛與功能喪失)。 ETQ /r/r 關即炎 關印炎本身有各種形式,某些較普遍形式包括類風濕性 關節炎,骨關節炎和概括性風濕症。 類風濕性關節炎為一種自體免疫性疾病,其特徵為關節 疼痛,腫脹和僵化,類風濕性關節炎為一種使約3 %美國 人’特別是女人罹受痛苦之疾病。類風濕性關節炎為一種 重度失能之疾病且通常會侵襲30至40歲之間的成人,而於 4 0 - 6 0歲間臨床病徵的發生率最高。雖然藥物治療十分有 效’但仍有多達7 %的類風濕性關節炎患者在疾病發作後5 年内即迅速殘廢到相當程度,且有多達5〇0/〇殘廢到不能工 作(Medical Sciences Bulletin,December 1994)。 經濟部中央標隼局員工消費合作杜印製 骨關節炎會產生類似於類風濕性關節炎之徵候。特別 者’雖然骨關節炎係從關節軟骨的變性起始而類風濕性關 節炎係從關節滑膜發炎開始的,但隨著疾病的進展,各程 序漸彼此趨近。於骨關節炎中,隨著軟骨惡化及關節嚙合 性的變更,常會發展出反應性關節滑膜炎。相對者,隨著 類風濕性關節炎侵敍軟骨,骨和軟骨中會發展出繼發性骨 關節炎變化。於骨關節炎和類風濕性關節炎兩者的末階 段’涉及的關節會顯得相同。 另有其它形式的關節炎,包括關節黏連型血清陰性脊椎 病(關節黏連性脊椎炎)和反應性關節炎。彼等病況常稱為 -5- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1 經濟部中央標準局員工消費合作社印製 A7 ^^ --------B7 _ 五、發明説明(3 ) B - 2 7關聯性疾病)且皆難以與類風濕性關節炎相區別。於 某些情況中,關節黏連性脊椎炎,賴透氏(Reiter)微候群或 牛皮癖性關節炎會在相同患者上與類風濕性關節炎同時存 在。於許多病例中,彼等患者係用與患有漸進性風濕性關 節炎者相同的疾病調節藥予以治療。 關節炎起始通常是在易罹患該疾病者3 〇歲後發生。不 過’某些形式的關節炎可能由不同肇因所起始,例如慢性 病毒感染。因為彼此之間有大幅重疊處,所以許多醫師將 彼等形式視為’,概括性風濕症”且用相同的方式處理彼等疾 病。落於此類的某些疾病包括慢性疲乏微候群,纖維性肌 痛(纖維組織炎)和痛風。事實上,對於某些患者,已有證據 累積顯不類風濕性關節炎與纖維性肌痛之間的重疊(Harris,Disaster response is any reaction that has the inflammatory characteristics defined above. It is well known to those skilled in the medical arts that the inflammatory response causes many physical discomforts (ie, pain and loss of function) associated with different diseases2 injuries. ETQ / r / r Guan Jiyan Guan Yinyan itself has various forms. Some of the more common forms include rheumatoid arthritis, osteoarthritis and generalized rheumatism. Rheumatoid arthritis is an autoimmune disease characterized by joint pain, swelling and stiffness, and rheumatoid arthritis is a disease that causes about 3% of Americans', especially women, to suffer. Rheumatoid arthritis is a severely disabled disease that usually affects adults between the ages of 30 and 40, with the highest incidence of clinical signs between the ages of 40 and 60. Although drug treatment is very effective ', as many as 7% of rheumatoid arthritis patients are rapidly disabled to a considerable extent within 5 years after the onset of the disease, and as many as 50,000 / 0 are disabled to be unable to work (Medical Sciences Bulletin , December 1994). Printed by the Consumers' Cooperation Program of the Central Bureau of Standards of the Ministry of Economic Affairs Osteoarthritis produces symptoms similar to rheumatoid arthritis. In particular, although osteoarthritis starts from the degeneration of articular cartilage and rheumatoid arthritis starts from the inflammation of the synovium of the joint, as the disease progresses, the procedures gradually approach each other. In osteoarthritis, reactive cartilage synovitis often develops with the deterioration of cartilage and changes in joint engagement. In contrast, as rheumatoid arthritis invades cartilage, secondary osteoarthritis changes develop in bone and cartilage. The joints involved in the final stages of both osteoarthritis and rheumatoid arthritis will appear the same. There are other forms of arthritis, including sero-negative spondylosis of the joints (joint spondylitis) and reactive arthritis. These conditions are often referred to as -5- This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 1 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 ^^ -------- B7 _ V. Description of the invention (3) B-2 7 related diseases) are difficult to distinguish from rheumatoid arthritis. In some cases, joint adhesion spondylitis, Reiter's microclimate, or psoriatic arthritis can coexist with rheumatoid arthritis in the same patient. In many cases, their patients were treated with the same disease-modifying drugs as those with progressive rheumatoid arthritis. The onset of arthritis usually occurs after the age of 30 in those who are susceptible to the disease. However, some forms of arthritis may be initiated by different causes, such as chronic viral infections. Because there is a substantial overlap with each other, many physicians treat their forms as ', generalized rheumatism' and treat them in the same way. Some diseases falling into this category include chronic fatigue microclimates, Fibromyalgia (fibromyalitis) and gout. In fact, for some patients, evidence has accumulated to show an overlap between rheumatoid arthritis and fibromyalgia (Harris,

Edward D. and W.B. Saunders,Rheumatoid Arthritis,1997)。 自體免疫疾病 如上文述及者,類風濕性關節炎為一種自體免疫疾病, 因此’其病原學與任何其它自體免疫性疾病的病原學頗為 相同。通常,身體會正常地辨識其本身的副產物與外來侵 入物(亦即,例如細菌,病毒,真菌與原生動物)之間的差 異。當一免疫細胞(T或B淋巴細胞)在其發育中對於,,自體蛋 白質"有反應,則該細胞即經視為有缺陷且通常會被破壞或 去活化。不過,有時候”自體反應性”免疫細胞會逃過被破 壞。在某一段時間後,該細胞可經活化且啟動免疫反應。 一般έ忍為活化作用的發生是在普通細菌或病毒感染後發 生,該細菌或病毒具有與缺陷性自體蛋白質上的一段胺基 -6 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) --- (請先閱讀背面之注意事項再填寫本頁)Edward D. and W.B. Saunders, Rheumatoid Arthritis, 1997). Autoimmune Diseases As mentioned above, rheumatoid arthritis is an autoimmune disease, so its etiology is quite the same as that of any other autoimmune disease. Normally, the body normally recognizes the differences between its own byproducts and foreign invaders (ie, bacteria, viruses, fungi, and protozoa, for example). When an immune cell (T or B lymphocyte) responds to, and autologous protein " in its development, the cell is considered defective and is usually destroyed or deactivated. However, sometimes “autoreactive” immune cells escape from being destroyed. After a certain period of time, the cells can be activated and initiate an immune response. In general, the activation occurs after common bacterial or viral infection, which has a segment of amine group-6 on the defective autoprotein-This paper size applies the Chinese National Standard (CNS) Α4 specification ( 210X297 mm) --- (Please read the notes on the back before filling this page)

1221772 A7 _______ B7_ 五、發明説明(4 ) fe鏈相吻合之一段胺基酸鏈。有數種細菌,例如鏈球菌 (Slreptococcns),黴槳菌 ^Mycoplasma),和疏螺旋體(borrelia) 以及某些病毒(亦即反轉錄病毒)涉及疾病的起始。除了類風 濕性關節炎之外,自體免疫常導致例如幼年型糖尿病,多 發性硬化症’ Graves氏症,Meneri氏症,重症肌無力,紅 斑後療和牛皮癖等疾病(Medical Sciences Bulletin,September, 1994)。 自體免疫會影響到特定的器官。例如,一些肝膽管道和 腎的自體免疫性疾病為:原發性膽硬化,壞死性腎絲球性 腎炎’自發性新月形腎絲球性腎炎,病毒謗發性肝和腎疾 病’慢性肝炎,自體免疫性肝炎和藥物謗發性肝炎 (Gershwin,Manns, and Mackey 1992)。並有報導指出蘭氏島的 免疫性破壞導致糖尿病(Hgopian and Lernmark 1 "2)以及胰島 素自體抗體(Palmer 1987)。 經濟部中央標準局員工消費合作社印製 有一大類的全身性脈管病經推測肇因於自體免疫機轉。 此類疾病中邵份為:白血球破損性血管炎,多動脈炎性結 郎,Goodpasture氏徵候群,川崎氏病,Wegner氏肉芽腫 病’ Churg-Struass徵候群,巨細胞動脈炎,Takayasu動 脈炎’免疫複合物媒介者’狼瘡,風濕症,與寒球蛋白血 型脈管炎,Henoch Sch0nlein紫癜病(Kallenberg,1996; Jennette, Jones,Falk,1992) ° 亦有許多證據顯示自體免疫可能在許多形式的心臟病中 有作用,包括:後心包膜切開和後心肌梗塞徵候群,心肌 炎,和自發性擴張型心肌病。自體免疫也可能促成急性心 本纸張尺度適用中國國家標準(CNS ) A4規格(210x 297公趁) 經濟部中央標準局員工消費合作社印製 1221772 A7 B7 五、發明説明(5 ) 肌疾病衍生成退化(Rose,Neumann,Burek,Herskowitz 1992)。 骨骨各肌的徵候性牽涉為許多自體免疫性所共同有者,例 如多發性肌炎或發炎性肌病(其可包括類風濕性關節炎,多 肌痛風濕症,重症肌無力,肌無力型肌病,神經性萎縮, 運動神經元病症,纖維性肌痛,纖維組織炎,肌肉營養不 良’内分泌性’代謝性’和癌性肌病)(Hollingsworth, Dawkins,Thomas 1992) 〇 有自體免疫源的其它疾病可為葡萄膜炎,Vogt-Koyanagi-Harada徵候群(Detrick ans Hooks 1992),和 Sj6gren 氏徵候 群,硬皮病,關節黏連性脊椎炎,皮肌炎,牛皮癬,皮牛 癬性關節炎,Reiter氏徵候群(NIH 1 994)。 自體抗體的跡象也出現於阿兹海默爾氏症(Singh et al·, 1992),痴呆症複徵(Mastroianni et al.,1991和孤獨癖兒重 (Singh et al,1993)。 有數種神經學性疾病例如,薛登漠氏舞蹈病,慢性強迫 觀念及強迫行為病(0CD),注意力缺乏性活動過度病 (ADHD),Tourette氏徵候群(丁 S)與某些精神分裂病可能具有 自體免疫成分且可能與抗一神經之抗體有關聯(Medical Sciences Bulletin,September,1994)。 上述概要說明並未涵蓋全部,且諳於此技者皆熟知有其 它自體免疫疾病,例如,Guillain-Barr6徵候群(自發裂多發 神經炎)。 治療 為了治療發炎相關疾病,常用的醫療作業為服用矸以減 -8- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 衣. 訂 1221772 A7 五、發明説明(6 體不適之藥劑。具有此類性質的藥劑分 發…抗發炎藥可用來治療廣範圍疾病,且〜, 用相同的藥物來治療不同的疾病。用抗發炎藥物二? 針對疾病,而常是針對徵候(亦即,發炎)。 療不疋 抗:炎藥物’鎮痛藥,和退熱藥為不 :化二常互為不相關者,但卻共有某些治療作用二 二二貝類固醇代表最廣用的治療發炎之化合物類別。蛋 刀解酵素代表另-類經認為具有抗發炎作用的化合物。 直接或間接促成腎皮質產生和分泌類固醇之激素代表另一 2發炎化合物。可惜的是’天,然和合成型皮質類固醇製 劑會引起許多嚴重的副作用,包括血壓增高,鹽和水 留,腎傷害及钾和舞加速排泄。再者,皮質類固醇可能掩 飾感染跡象及增進感染性微生物的散布。這些激# 不能安全地用於懷孕婦女,且長期的皮質類固醇治::胃 過度活動及/或胃潰瘍有相關聯。用皮質類固醇治療也可能 加重糖尿病,需要更高劑量的胰島素,且可能產生精^ 病。激素類抗發炎藥中會間接增加内源性皮質類固醇者也 具有相同的不良副作用潛在性。 經濟部中央標準局員工消費合作社印製 對於發炎,且特別是類風濕性關節炎,其它關節炎與其 匕自體免疫性疾病之另一種常用治療方式為藥物治療。一 般而1*,患者係在開始時經用,,第一線”藥劑,常為主要為 纾解徵候的非類固醇抗發炎藥(NSAIDS)予以治療。患者於 隨後係用”第二線”或疾病調解劑(DMARDS)予以治療,例 如用氨甲蝶呤,金化合物,青黴素胺,sulfasalazlne,和 本纸張尺度適用中國國家標準(CNS ) A4規格(2丨0χ297公羞 72 7 11 2 12 A7 B7 五、發明説明(7 ) 抗癔藥。不過,所有上述藥物都具有嚴重的副作用,特別 是以高劑量服用時。例如,阿斯匹靈,一種NS AID,可能 造成消化不良和胃痛;保泰松(phenylbutazone)可能產生 胃潰瘍而非那西汀(phenacetin)可能導致腎疾病。氨甲蝶 呤可能造成口腔潰瘍和胃腸(GI)副作用。 若可以得到具有抗發炎作用的天然食品時,就可提供容 易給藥,輕易可得,且安全的治療組合物來治療關節炎, 自體免疫疾病及一般性發炎。 經濟部中央標率局員工消費合作社印製 鳥綱的各屬,例如雞(Gallus d〇mesti cus、,火難和鴨, 會在血液和卵中產生對抗引起禽類疾病的免疫原以及對抗 其它免疫原之抗體。例如,LeBacq-Verheyden et al. (Immunology 27:683 (1994))和 leslie,G.A· et al. (J. Med. 130:1337 (1969)),曾定量地分析過難的免疫球蛋白。Dolson, A. et al. (Immunological Communications 9:495-514 (1980))將母 難免疫化以對抗幾種蛋白質和天然蛋白質混合物,而在卵 的卵黃中偵檢出 IgY抗體。Fertel. R. et al. (Bio-chemical and Biophysical Research Communications 102:1028-1033 (1981))將 母雞針對前列腺素免疫化而在卵黃中偵檢出抗體。Jensenins et al. (Journal of Immunological Methods 46:63-68 (198 1))提出 一種分離卵黃IgG以用於免疫診斷之方法。Poison et al. (Immunological Communications 9:475-493 (1980))述及從用多 種植物病毒免疫處理過的母難之卵黃中分離出抗體。 美國專利第4,3 5 7,2 7 2號揭示出從經超免疫化的母難所生 的卵之卵黃分離出抗體。該超免疫化係經由重複注射衍生 -10 · 纸張尺度適用中國國家CNS ) A4規格(210\ 297公釐1 · 經濟部中央標準局員工消費合作社印製 1221772 A7 B7 五、發明説明(8 ) 自植物病毒,人類IgG,破傷風抗毒素,抗蛇毒血清,和 Serameba之免疫原予以謗發的。美國專利第4,55〇,〇19號 揭π從以至少3 0, 〇〇〇的分子量或粒子重之免疫原超免疫的 母難之卵5中分離出抗體。將難超免疫化所用的免疫原係 選自植物病毒,人類免疫球蛋白,破傷風抗毒素,和蛇毒 之中者。 美國專利第4,748,0 1 8號揭示一種哺乳動物的被動免疫 處理,其包括非經腸地給用得自經針對相對抗原免疫化的 尚類所生卵I經純化抗體,且其中該哺乳動物獲得針對卵 的免疫性。 美國專利第5,772,999號(受讓於DCV-Bi〇1〇gics)揭 不一種預防,對抗或減輕患者慢性胃腸病或非類固醇抗發 炎藥誘發(NSAID-誘發)胃腸傷害之方法,其包括給該患 者服用經超免疫化的卵及/或牛奶或其部份。 不過,泛些參考又獻皆無揭示或推測卵在給動物服用時 ^有預防或減輕發炎’治療或預防關節炎或治療或預防自 也免疫疾病之力。而且這些參考文獻也沒有揭示或推測 出一種方法其可揭供合理地預期禽類超免疫化可產生會產 下具有該能力的卵之禽類。最後,這些參考文獻也未揭示 或推測家禽的印中會含有抗發炎組合物。 本發明係本案發明人的發現為基礎,亦即卵與卵產物中 含有抗發炎活性’特別是從經超免疫化的禽類所得卵產 物,其在給個體動物,特別者,哺乳動物,服用時,可預1221772 A7 _______ B7_ V. Description of the invention (4) The fe chain coincides with a segment of amino acid chain. There are several types of bacteria, such as Slreptococcns, Mycoplasma, and Borrelia, and certain viruses (retroviruses) are involved in the onset of disease. In addition to rheumatoid arthritis, autoimmunity often causes diseases such as juvenile diabetes, multiple sclerosis, Graves' disease, Meneri's disease, myasthenia gravis, post-erythema therapy, and psoriasis (Medical Sciences Bulletin, September , 1994). Autoimmune affects specific organs. For example, some autoimmune diseases of the hepatobiliary ducts and kidneys are: primary biliary sclerosis, necrotizing glomerulonephritis, 'spontaneous crescent glomerulonephritis, virus, liver and kidney disease, chronic Hepatitis, autoimmune hepatitis, and drug-induced hepatitis (Gershwin, Manns, and Mackey 1992). It has also been reported that the immune disruption of Lang's Island causes diabetes (Hgopian and Lernmark 1 " 2) and insulin autoantibodies (Palmer 1987). Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs. A large class of systemic vascular disease is presumed to be caused by autoimmune mechanisms. The components of this type of disease are: leukocyte vasculitis, polyarteritis inflammation, Goodpasture's syndrome, Kawasaki disease, Wegner's granulomatosis' Churg-Struass syndrome, giant cell arteritis, Takayasu arteritis 'Immune complex mediators' lupus, rheumatism, and cryoglobulinemia vasculitis, Henoch Schonlein purpura (Kallenberg, 1996; Jennette, Jones, Falk, 1992) ° There is also much evidence that autoimmunity may Forms of heart disease have a role, including: posterior pericardial incision and posterior myocardial infarction syndrome, myocarditis, and spontaneous dilated cardiomyopathy. Autoimmune may also contribute to acute heart-size paper. Applicable to China National Standard (CNS) A4 (210x 297). Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 1221772 A7 B7 V. Description of the invention (5) Derivation of muscle diseases (Rose, Neumann, Burek, Herskowitz 1992). Symptoms and symptoms are common to many autoimmune individuals, such as polymyositis or inflammatory myopathy (which may include rheumatoid arthritis, polymyalgia rheumatism, myasthenia gravis, muscles Weakness-type myopathy, neurotrophic atrophy, motor neuron disorders, fibromyalgia, fibrous tissue inflammation, muscular dystrophy 'endocrine' metabolic and cancerous myopathy) (Hollingsworth, Dawkins, Thomas 1992) Other diseases of autoimmune origin can be uveitis, Vogt-Koyanagi-Harada syndrome (Detrick ans Hooks 1992), and Sj6gren's syndrome, scleroderma, arthritis spondylitis, dermatomyositis, psoriasis, skin Psoriasis arthritis, Reiter's syndrome (NIH 1 994). Signs of autoantibodies also appear in Alzheimer's disease (Singh et al., 1992), relapses in dementia (Mastroianni et al., 1991, and autism) (Singh et al, 1993). There are several Neurological diseases such as Schodenmo's chorea, chronic obsessive-compulsive disorder and obsessive-compulsive behavior disorder (0CD), attention deficit hyperactivity disorder (ADHD), Tourette's syndrome (D S) and some schizophrenia may have Immune components and may be associated with antibodies against a nerve (Medical Sciences Bulletin, September, 1994). The above summary does not cover all, and those skilled in the art are familiar with other autoimmune diseases, for example, Guillain- Barr6 syndrome (spontaneous fissure polyneuritis). Treatment In order to treat inflammation-related diseases, the common medical operation is to take 矸 minus -8-This paper size applies the Chinese National Standard (CNS) A4 size (210X297 mm) (please first Read the precautions on the reverse side and fill out this page). Order 1221772 A7 V. Description of the invention (6 Medicines with physical discomfort. Distribution of medicines of this nature ... Anti-inflammatory drugs can be used for treatment Range of diseases, and ~, use the same drug to treat different diseases. Use anti-inflammatory drugs two? Target the disease, but often the symptoms (ie, inflammation). Treatment is not resistant: inflammatory drugs' analgesics, and withdrawal Fever medicine is not: Hua Er Chang often is irrelevant, but there are certain therapeutic effects. 222 shellfish steroids represent the most widely used class of compounds to treat inflammation. Egg knife enzymes represent another-class that is considered to have anti-inflammatory properties. Compounds that work. Hormones that directly and indirectly cause the production and secretion of steroids in the renal cortex represent another 2 inflammatory compounds. Unfortunately, 'natural, and synthetic corticosteroid preparations can cause many serious side effects, including increased blood pressure, salt and water Retention, kidney injury, and accelerated excretion of potassium and dance. Furthermore, corticosteroids may mask signs of infection and promote the spread of infectious microorganisms. These stimuli # cannot be safely used in pregnant women and long-term corticosteroids :: gastric overactivity And / or gastric ulcers. Treatment with corticosteroids may also exacerbate diabetes, require higher doses of insulin, and may Spermatogenic disease. Those who indirectly increase endogenous corticosteroids in hormonal anti-inflammatory drugs have the same potential for adverse side effects. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs for inflammation, and especially rheumatoid arthritis Another commonly used treatment for other arthritis and its autoimmune diseases is drug therapy. Generally, 1 *, patients are used at the beginning, and the first-line "medicine" is often a non-medical drug that mainly relieves symptoms. Steroid anti-inflammatory drugs (NSAIDS) are treated. Patients are subsequently treated with "second-line" or disease mediators (DMARDS), such as methotrexate, gold compounds, penicillinamine, sulfasalazlne, and this paper Applicable to China National Standard (CNS) A4 specification (2 丨 0χ297 public shame 72 7 11 2 12 A7 B7 V. Description of the invention (7) Anti-paeonia. However, all of these drugs have severe side effects, especially when taken in high doses. For example, aspirin, an NS AID, can cause indigestion and stomach pain; phenylbutazone can cause gastric ulcers, but not phenacetin, which can cause kidney disease. Methotrexate may cause oral ulcers and gastrointestinal (GI) side effects. If natural foods with anti-inflammatory effects are available, they can provide easily administered, readily available, and safe therapeutic compositions for the treatment of arthritis, autoimmune diseases, and general inflammation. The genus of birds, such as chickens (Gallus domesti cus, fire disaster, and ducks), produced by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs will produce immunogens in blood and eggs that fight poultry diseases and other immunogens Antibodies such as LeBacq-Verheyden et al. (Immunology 27: 683 (1994)) and leslie, GA. Et al. (J. Med. 130: 1337 (1969)), have quantitatively analyzed difficult immunoglobulins Protein. Dolson, A. et al. (Immunological Communications 9: 495-514 (1980)) immunized the mother against several proteins and natural protein mixtures, and detected IgY antibodies in the yolk of eggs. Fertel. R. et al. (Bio-chemical and Biophysical Research Communications 102: 1028-1033 (1981)) immunized hens against prostaglandins to detect antibodies in yolk. Jensenins et al. (Journal of Immunological Methods 46: 63-68 (198 1)) proposes a method for isolating yolk IgG for immunodiagnosis. Poison et al. (Immunological Communications 9: 475-493 (1980)) addresses the difficulty of immunizing mothers treated with various plant viruses. Yolk isolated U.S. Patent No. 4,3 5 7,2 7 2 discloses the isolation of antibodies from the yolk of ovum produced by hyperimmune mothers. This hyperimmune system is derived by repeated injections. National CNS of China) A4 size (210 \ 297 mm1) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1222172 A7 B7 V. Description of the invention (8) From plant viruses, human IgG, tetanus antitoxin, anti-venom serum, and Serameba The immunogen was defamated. U.S. Patent No. 4,55,0019 discloses the isolation of antibodies from the hard-to-female eggs 5 that are hyperimmunized with an immunogen having a molecular weight of at least 30,000 or a particle weight. . The immunogen used for difficult hyperimmunization is selected from the group consisting of plant virus, human immunoglobulin, tetanus antitoxin, and snake venom. US Patent No. 4,748,0 18 discloses a passive immune treatment for mammals, including A parenterally administered purified antibody obtained from egg I that has been immunized against a relative antigen, and the mammal acquires immunity to the egg. US Patent No. 5,772,999 (assigned to DCV-Bi. 1〇gic s) A method for preventing, combating or reducing chronic gastrointestinal disease or non-steroidal anti-inflammatory drug-induced (NSAID-induced) gastrointestinal injury in a patient, which comprises administering the patient with hyperimmune eggs and / or milk or parts thereof Serving. However, there are no general references to reveal or speculate that eggs when administered to animals have the power to prevent or reduce inflammation 'to treat or prevent arthritis or to treat or prevent autoimmune diseases. Moreover, these references do not reveal or speculate a method that could reasonably be expected to result in hyperimmunization of poultry that would produce poultry that would lay eggs with this ability. Finally, these references do not disclose or speculate that poultry's seals would contain anti-inflammatory compositions. The present invention is based on the findings of the inventors of the present case, that is, eggs and egg products contain anti-inflammatory activity, especially egg products obtained from hyperimmune birds, which are given to individual animals, especially mammals, when taken. , Predictable

/72五 '發明説明(9 經濟部中央標準局員工消費合作社印製 防或減低彼等動物的發炎。 特定言之,本發明係有關 炎組合物。該抗發炎组合物n I 〜純化《抗發 了以邵份純化過者。 刀w 本發明也有關一種超免疫仆 甘7 1 又化万法,其可在禽卵中產生超 正吊水平的抗發炎組合物。安 化4w本發月人L為經由該超免疫 了曰加蛋更和蛋白中的抗發炎組合物水平。 本發明也涵蓋—種治療患者且㈣是哺乳動物發炎之方 法,其包括給該患者服用部份純的抗發炎組合物或含有該 部份純抗發炎組合物之組合物。此部份涵蓋服用整個蛋本 身及/或其部份體。 本發明更基於本案發明人的發現,亦即在卵中和卵產品 中具有活性,具特別是在得自經超免疫化的禽類之印產 物,其給個體動物,特別是哺乳動物服用時,可治療或預 防該個體動物的關節炎及/或自體免疫疾病。 h ^ 取後,本發明係有關一種方法,其中係將卵產品組合著 遠自非類固醇抗發炎藥物和疾病調節性抗關節炎藥物所成 組合中的藥物給個體動物服用。 附圖之簡單說明 圖1為從經粉化的卵黃純化出低於3,000分子量的抗發 炎組合物之流程圖。 圖2為從經粉化物卵白純化出低於3,〇 〇 〇分子量的抗發 炎組物之流程圖。 圖3為用S e p h ar 〇 s e管柱分離經部份純化抗發炎組合 物 (請先閲讀背面之注意事項再本頁一/ 72 Five 'Invention Description (9 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs to prevent or reduce the inflammation of their animals. In particular, the present invention is related to inflammation compositions. The anti-inflammatory composition n I ~ The present invention also relates to a kind of hyper-immune immune system, which can produce an anti-inflammatory composition with ultra-positive levels in poultry eggs. Anhua 4w this month Human L is the level of anti-inflammatory composition in egg white and protein via this hyperimmunization. The present invention also encompasses a method of treating a patient who is not mammalian, including administering to the patient a portion of pure anti-inflammatory Inflammatory composition or a composition containing the partially pure anti-inflammatory composition. This part covers taking the whole egg itself and / or a part thereof. The present invention is further based on the findings of the inventor of the present case, that is, in eggs and eggs It is active in the product, especially when it is obtained from a hyperimmunized poultry product, which can be used to treat or prevent arthritis and / or autoimmune diseases of an individual animal, especially a mammal. H ^ Then, the present invention relates to a method in which an egg product is administered to an individual animal in combination with a drug far from a combination of a non-steroidal anti-inflammatory drug and a disease-modulating anti-arthritis drug. Brief Description of the Drawings Figure 1 is Flow chart of purifying anti-inflammatory composition with molecular weight below 3,000 from powdered egg yolk. Figure 2 is a flow chart of purifying anti-inflammatory composition with molecular weight below 3,000 from powdered egg white. Figure 3 In order to separate the partially purified anti-inflammatory composition with a Sephor arse column (please read the precautions on the back first and then the first page)

I H·· —ϋ I -訂 -12 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 1221772 五、發明説明(10 經濟部中央標準局員工消費合作社印製 之吸光度圖。 Θ為彳火超免疫卵黃分離經部份純化抗發炎組合物之 Η P L C層析譜。二L為顯示出用老鼠第11型膠原模型顯示出超免疫卵對 於關即炎發生的影響之圖形。 么=6為顯示出超免疫卵,其部份體及經部份純化抗發炎 、且e物對於老鼠第丨丨型膠原模型中的關節炎嚴重度之 的圖形。 ”曰 發明之詳細說明 本發明概括地有關治療和預防概括性發炎,且特別者關 即炎和自體免疫性疾病之組合物和方法。該組合物較佳者 為包括超免疫卵或卵產物之天然食品。該食品於依本發明 方法給用時,不僅可提供將關節炎和自體免疫性疾病所引 起的疼痛和其它微候予以減輕之效果,而且可延缓,且甚至 於預防彼等疾病的起始。注射到禽類以產生超免疫卵產物 所用的車父佳抗原混合物不含已知會引起發炎或自體免疫疾 病之特殊抗原。所以,令人訝異者,從針對混合抗原疫苗 免疫化的家禽所得超免疫卵或卵產物在給患者服用時竟然 可以有效地減輕發炎和自體免疫性疾病的徵候及預防彼等 的發生。 定義 下面的定義應用於本文全文中: ,’發炎” 一詞依其經技藝公認的意義使用,係指一種由組 織受傷或破壞所謗發的局部性保護反應以用來破壞,淡化或 -13- 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 請 ka 閱 讀 背 I 事 項填· 本 頁 裳 ijIH ·· —ϋ I -Order-12 This paper size is applicable to China National Standard (CNS) A4 specification (210X 297mm) 1221772 5. Description of the invention (10 Absorbance chart printed by the Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs. Θ is the Η PLC chromatogram of the partially purified anti-inflammation composition isolated from the fiery hyperimmune yolk. The two L is a graph showing the effect of hyperimmune eggs on the occurrence of guan ji inflammation using a mouse type 11 collagen model. Mo = 6 is a graph showing hyperimmune eggs, some of which are partially and partially purified anti-inflammation, and e-substances on the severity of arthritis in a rat collagen type 丨 丨 model. "A detailed description of the invention The invention relates generally to compositions and methods for the treatment and prevention of generalized inflammation, and in particular to inflammation and autoimmune diseases. The composition is preferably a natural food product including hyperimmune eggs or egg products. The food product is When administered according to the method of the present invention, it not only provides the effect of reducing pain and other microclimates caused by arthritis and autoimmune diseases, but also delays and even prevents the onset of those diseases. Beginning. Injections into birds to produce hyperimmune egg products are free of specific antigens known to cause inflammation or autoimmune diseases. So, surprisingly, poultry immunized from mixed antigen vaccines The resulting hyperimmune eggs or egg products can effectively reduce the symptoms of inflammation and autoimmune diseases and prevent them from occurring when administered to patients. Definitions The following definitions apply throughout this article: "Inflammation" Its technically accepted meaning refers to a local protective response issued by tissue injury or destruction for destruction, dilution or -13- This paper size applies to China National Standard (CNS) A4 (210X 297) Mm) Please read the note on the back of I. This page

I A7 B7 五、發明説明(11 ) 堵塞傷害劑和受傷相純 式中,其特徵在於有;:者二其不恰當,未經控制的形 失之典型順序,且1::!熱,發、红,腫脹,和功能喪 括小動脈,微血管/和二―複雜的事件系列,包 源部位内。 、勺一泌出,及白血球移動到發炎 相:::二:H意指顯示出結缔組織構造,特別是關節和 :以又火和k性〈任何種疾病。其可能伴有疼痛,僵 ,,㈣科料動受_。某些關節炎料包括風濕 =卽炎’骨關節a,關節黏連性血清陰性脊椎病,反應 性關節炎’慢性疲乏微候群’纖維性肌痛(纖維織炎)和痛 風。 &quot;自體免疫性疾病,,係以標準醫學字典例如D〇riand,s和 abers中所載;^準醫學^義而用。各種自體免疫性疾病的 說明可參看本文件的”背景,,段。 超^免疫化一同意指暴露於一或更多種抗原使得免疫反 應增^且保持在自然未經暴露狀態之上。 卵或卵產物”二詞各指任何整粒卵(食用(tabk))卵, 經濟部中央標準局員工消費合作社印製 經超免疫化或其它)或從彼衍生的任何產物或部份體。 Π食用卵”或”食用卵產物&quot;二詞各指從未保持在超免疫狀 悲的產卵動物所得全卵或從其衍生的任何產物或部份體。 超免疫卵”或”超免疫卵產物&quot;二詞各指從保持在超免疫 狀態的產卵動物所得全卵或其所衍生的任何產物或部份 體。 , -14 - 本紙張尺度適用巾@國家標準(CNS ) Μ規格(21Qx297公楚 1221772 Α7 Β7 經濟部中央標準局員工消費合作社印製 五、發明説明(12 超正常水平”意指超過未保持在超免疫狀態中的產卵動 物所生卵中測得者之水平。 ”抗發炎性卵或卵部份體,,一詞意指含有本文所示的抗發 炎性組合物之卵或卵部份體。 ’’抗發炎性組合物”意指可抵消或壓抑發炎程序的本案組合 物。 ’’邵份純的卵抗發炎組合物”意指具有至少為實施例丨0及 其例示物質和圖式(補充說明書)中所述純度之抗發炎性組合 物。 ’’組合衍生免疫原”指經由組合合成方式產生分子歧異型 免疫原之程序。 生物工程免疫原”一詞指的是經由基因選殖技術方法及 使具有抗原性質的蛋白質嵌入和轉譯之基因處理得到之免 疫原。 基因疫苗π —詞指的是通常係經由重組技術所產生且可 誘發免疫反應之核酸疫苗。 •’治療’’ 一詞意指疾病徵候(包括疼痛)及/或疾病的病原之 發作被延緩或芫全遏止,或,若存在時,該徵候被減輕或 完全消除掉。例如,超免疫卵產物可治療關節炎及/或自體 免疫疾病其不僅可壓抑人類和其它動物的疾病微候,而且 可作為預防劑以抵消受藥者的疾病存在。 預防一同意指疾病的進展被減緩及/或消除,或疾病的 起始被消除。 給藥”一詞意指提供物質給患者之任何方法,包括經 -15- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁) r裝_ :訂 Α^ι/72 經濟部中央標準局員工消費合作社印製 五、發明説明(13 ) π内非經腸(靜脈内,肌肉内,或皮下),經直腸,局 部或經眼内。 ’’動物”一詞意指動物界定義。 榇的動物指的是作為卵或卵產物產生動物之動物。 ’’個體動物&quot;一詞指的是給用由標的動物產生的卵或卵產 物之動物。 &quot;免疫原’’ 一詞指的是能夠誘發體液抗體及/或細胞媒介免 疫反應而#免疫學耐受性之物質。㈣&amp;示刺丨敫免疫反應 以及與其產物(即抗體)反應之能力。 本發明 本發明產物和方法特別有關係為天然食品超免疫卵在治 療和預防發炎性與自體免疫性疾病上之用途。由於是天然 者所Χ此種良口口可用來治療和預防彼等疾病,當然, 除對卵有不耐性者的過敏反應之外,不怕有副作用發 生。 於只施例中,本發明包括超免疫卵或卵產物,其可以 有效地治療和預防個體動物關節炎及/或自體免疫性疾病。 該超免疫卵係得自產㈣物,且更特別是禽類,其係經用 土 ν種免疫原予以超免疫化者。超免疫卵產物較佳者為 經口給個體動物服用者。該超免疫卵或卵產物可更分離成 更有放力的#伤髂其可於隨後以各種形式給個體動物服 用。 於另見她例中,本發明包括得自禽卵的抗發炎組合物, 其部份純化,及其經部份純化組合物給患者服用以治療發 16- 本紙張尺度_ t _家標準(CNS ) 公釐 (請先閲讀背面之注意事項再填寫本頁)I A7 B7 V. Description of the invention (11) In the pure formula for clogging the wounding agent and the injured phase, it is characterized by: 2: the second is its improper, typical sequence of uncontrolled loss, and 1 ::! , Redness, swelling, and function include arterioles, microvessels, and II-a complex series of events, including within the source site. 1. Spoon exudates, and white blood cells move to inflammation. Phase ::: two: H means to show connective tissue structure, especially joints and: to fire and k sex <any kind of disease. It may be accompanied by pain, stiffness, and dysfunction. Certain arthritis materials include rheumatism = osteoarthritis' bone and joint a, joint adhesion seronegative spondylopathy, reactive arthritis' chronic fatigue microclimate 'fibromyalgia (fibritis) and gout. &quot; Autoimmune diseases are used in standard medical dictionaries such as Doriand, s and abers. A description of various autoimmune diseases can be found in the "Background," paragraph of this document. Hyperimmunization-consent means that exposure to one or more antigens increases the immune response and maintains the natural unexposed state. The term "egg or egg product" refers to any whole egg (tabk) egg, any product or part thereof derived from or printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs, printed by a hyper-immunized or otherwise. The terms "edible egg" or "edible egg product" each refer to a whole egg or any product or part thereof derived from an oviparous animal that has never remained in a hyperimmune state. The terms "hyperimmune egg" or "hyperimmune egg product" each refer to a whole egg or any product or part thereof derived from an oviposition animal maintained in a hyperimmune state. -14-This paper size applies towels @National Standards (CNS) M specifications (21Qx297 Gongchu 1221772 Α7 Β7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economy Levels measured in eggs produced by egg-laying animals in a hyperimmune state. "Anti-inflammatory egg or egg part body," the term means an egg or egg part containing an anti-inflammatory composition as shown herein "An anti-inflammatory composition" means a composition of the present case that can counteract or suppress the inflammatory process. "Shao Fen's pure egg anti-inflammatory composition" means a compound having at least Examples and their exemplified substances and figures. An anti-inflammatory composition of the purity described in the formula (Supplementary Note). "Combined-derived immunogen" refers to the process of generating molecularly differentiated immunogens by combinatorial synthesis. The term "bioengineered immunogens" refers to genetic selection Method and genetically-immunized protein obtained by embedding and translating proteins with antigenic properties. Gene vaccines π — The term refers to those that are usually produced by recombinant technology and can be induced A nucleic acid vaccine for disease response. • The term 'treatment' means that the onset of disease symptoms (including pain) and / or the cause of the disease is delayed or completely suppressed, or, if present, the symptoms are reduced or eliminated altogether. For example, hyperimmune egg products can treat arthritis and / or autoimmune diseases. They can not only suppress the disease microclimate of humans and other animals, but also act as a preventive agent to offset the presence of disease in the recipient. Prevention-consent refers to disease The progress of the disease is slowed and / or eliminated, or the onset of the disease is eliminated. The term "administration" means any method of providing a substance to a patient, including the application of Chinese National Standard (CNS) A4 specifications (-) 210X 297 mm) (Please read the notes on the back before filling out this page) r Pack_: Order Α ^ ι / 72 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (13) Non-intestinal (Intravenous, intramuscular, or subcutaneous), rectal, topical, or intraocular. The term "animal" means the definition of the animal kingdom. "Animal" means an animal that produces an animal as an egg or egg product. ' The term "individual animal" refers to an animal that uses eggs or egg products produced by the target animal. "The term" immunogen "refers to the ability to elicit humoral antibodies and / or cellular-mediated immune responses and Substances that are susceptible. 敫 &amp; shows the ability to react and react with its products (ie, antibodies). The products and methods of the present invention are particularly relevant for the treatment and prevention of inflammatory and autoimmunity in natural food hyperimmune eggs. Uses on sexual diseases. Since they are natural, this kind of mouth can be used to treat and prevent those diseases. Of course, in addition to allergic reactions to people with egg intolerance, they are not afraid of side effects. In the present invention, the present invention includes hyperimmune eggs or egg products, which can effectively treat and prevent arthritis and / or autoimmune diseases in individual animals. The hyperimmune egg line is obtained from maggots, and more particularly birds, which are hyperimmune with soil ν immunogens. The hyperimmune egg product is preferably administered to an individual animal orally. This hyperimmune egg or egg product can be more isolated into more laxative #trauma, which can be subsequently administered to individual animals in various forms. In another example, the present invention includes an anti-inflammatory composition obtained from poultry eggs, partially purified, and a partially purified composition administered to a patient to treat hair. CNS) mm (please read the notes on the back before filling this page)

!221772 A7 B7 五、發明説明(14 請 閲 讀 背 面 意 事 項 再λ 填籲r 本衣 頁 炎。本發明更包括從用一或多種免疫原,且特別者,細菌 抗原,或彼等的合成等效物予以超免疫化的禽卵經部份純 化所得相同抗發炎性組合物。該抗發炎性組合物係以超正 第水平存在於超免疫卵内而提供抗發炎活性給個體動物。 下面給出本發明的細部說明。 純化程序 沒P k發炎組合物可從全卵’卵黃或卵白經部份純化而 得。較佳的部份純化程序之一例子如下: 1. 從一卵準備水溶性部份物; 2. 將該水溶性部份物超濾; 3·經由離子或陰離子交換層析術分離諸部份物;及 fr 4,生物檢定諸經分離出的部份物之抗發炎活性。 下面為此程序的更詳細說明: 經濟部中央標準局員工消費合作社印製 該抗發炎組合物可從全卵,卵黃或卵白部份純化出。於一 較佳實施例中,該組合物係從卵黃純化的。經由諳於此技 者所熟知的方法從全卵或卵黃脫除掉脂質部份。例如,於 經噴霧乾燥卵黃粉末的情況中,可用溶劑(丙烷,丁烷或己 浼或用二兀溶劑),超臨界C〇2,酵素等完成脫脂,而於液 態卵黃之情況中,可用Lee所揭示的辛酸分離方法(美國專 利第5,3 67,054號)完成脫脂。對於卵白不需脫脂,因此可 用慣用方法與依下文實施例中所述者將液體或粉末形式的 卵白直接加熱或溶解。之後,全卵,卵黃或卵白較佳者再 處理成液體或粉末形式,且更進一步處理而得水溶性部份 17- 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐 1221772 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(15 ) 物(參看實施例)。 步騾2 : 從全卵,卵黃或卵白所得水溶性部份物係經用裝有3,〇〇〇 分子I截止膜的超濾系統予以超濾。該超濾程序可將有大 於約3,000道耳呑(dalt〇ns)分子量的分子與有低於約⑽〇 道耳呑分子量的分子分離開。在超濾後,即將所得含有低 於約3,000遒耳呑分子量的分子之超濾物冷凍乾燥,稱重, 及準備供生物檢定檢驗所用以及進一步分離。 步驟3 : 得自低於3,000道耳呑超濾物的部份物可經由,例如,逆 相南性也液體層析術予以分離更純化該部份純的抗發炎組 合物。作為取代或附加的策略者,於超濾物中的卵抗發炎 組合物可用陰離子交換DEAE-Sephar〇se層析術再分析。 於一特殊揭示實施例中,較佳的超濾係以Amic〇n RA1000 (3K MWCO)和DEAE離子交換層機術行之。不超,要了解 者’根據本文資料’及謂於此技者可得知識,可以使用同 效性技術和材料來分離組合物。 步騾4 : 組合物所具抗發炎活性可用測定抗發炎活性的標準生物檢 定法予以檢驗。與其它一起的某些例子包括白血球滲移的 抑制,老鼠爪水腫檢驗,佐劑謗導關節炎,膠原謗發關節 炎,及生命期内顯微術。此外也可以進行卵抗發炎組合物 與已知的抗發炎導物例如阿斯匹靈與消炎痛(indomethacin) 之比較。最後,可以使用對於風濕性關節炎,變性關節炎-18- (請先閱讀背面之注意事項再填寫本頁) -emmBm n i_l« KKK aMmmB mmmmme j -Kmt IK o— BmmK —Bn- ir -1^ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1221772 A7 B7 五、發明説明(16 ) 和傷¥謗導關節炎之臨床檢驗來測定抗發炎活性。 部份純卵抗發炎組合物所具抗發炎作用係以生物檢定予以 ’/、J里。較佳的生物檢定為如貫施例6中列出的老鼠第11型膠 原檢定。 另一種生物檢定包括胸膜白血球移動抑制檢定;如下列資 料中所載者:Vinegar et al,,,Some Quantitative Characteristics of Carrageenan Induced Pleurisy in the Rat,’’Proc. Soc. Exp· Bio· Med· 143: 711_714 ( 1 973), Ammendola,G. et al., &quot;Leukocyte Migration and Lysozomal Enzymes Release in Rat Carrageenan Pleurisy, &quot;Agents and Actions 5:250-255 (1975) ’ Vinegar, R et al.5 &quot;Quantitative 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁)221772 A7 B7 V. Description of the invention (14 Please read the notice on the back and then fill in the apical syringitis. The present invention also includes the use of one or more immunogens, and in particular, bacterial antigens, or their synthesis, etc. The same anti-inflammatory composition is obtained by partially purifying the poultry eggs that have been hyperimmune with the effective substance. The anti-inflammatory composition is present in the hyperimmune eggs at an ultra-high level to provide anti-inflammatory activity to individual animals. The detailed description of the present invention is given. Purification procedure The P k inflammatory composition can be partially purified from whole eggs' yolk or egg white. An example of a preferred partial purification procedure is as follows: 1. Prepare water-soluble from an egg Fractions; 2. ultrafiltration of the water-soluble fractions; 3. separation of fractions by ion or anion exchange chromatography; and fr 4, bioassay of anti-inflammatory activity of the fractions isolated The following is a more detailed description of this procedure: The anti-inflammatory composition printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs can be purified from whole eggs, yolk or egg white. In a preferred embodiment, the composition is From yolk Purified. Lipid fraction is removed from whole eggs or yolk by methods known to those skilled in the art. For example, in the case of spray-dried yolk powder, a solvent (propane, butane or hexane or (Solvent solvent), supercritical CO2, enzymes, etc. to complete degreasing, and in the case of liquid egg yolk, decapidation can be accomplished using the caprylic acid separation method disclosed by Lee (U.S. Patent No. 5,3 67,054). Therefore, conventional methods can be used to directly heat or dissolve egg white in liquid or powder form as described in the examples below. After that, the whole egg, egg yolk or egg white is preferably processed into liquid or powder form and further processed. Water-soluble part 17- This paper size applies to Chinese National Standard (CNS) A4 specifications (210X 297 mm 1221772 A7 B7. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of invention (15) (see examples) Step 2: Water-soluble fractions obtained from whole eggs, yolks, or whites are subjected to ultrafiltration using an ultrafiltration system equipped with a 3,000 molecular I cut-off membrane. Molecules with a molecular weight of about 3,000 Daltons are separated from molecules with a molecular weight below about 100 Daltons. After ultrafiltration, the ultramolecular weight of molecules with molecular weights below about 3,000 Daltons is obtained. The filter is lyophilized, weighed, and ready for bioassay testing and further separation. Step 3: The fraction obtained from less than 3,000 channels of urinary ultrafiltration can be passed through, for example, reverse phase south liquid chromatography The partially pure anti-inflammatory composition was separated and purified. As an alternative or additional strategy, the egg anti-inflammatory composition in ultrafiltration can be reanalyzed by anion exchange DEAE-Sepharose chromatography. In the specifically disclosed embodiment, the preferred ultrafiltration system is performed with Amicon RA1000 (3K MWCO) and DEAE ion exchange layer machine. No, for those who know ‘according to this document’ and what is known to those skilled in the art, they can use equivalent techniques and materials to isolate the composition. Step 4: The anti-inflammatory activity of the composition can be tested by standard bioassay methods to determine the anti-inflammatory activity. Some examples among others include inhibition of white blood cell migration, rat paw edema testing, adjuvant-induced arthritis, collagen-induced arthritis, and life-time microscopy. It is also possible to compare egg anti-inflammatory compositions with known anti-inflammatory guides such as aspirin and indomethacin. Finally, you can use rheumatoid arthritis, degenerative arthritis-18- (Please read the precautions on the back before filling this page) -emmBm n i_l «KKK aMmmB mmmmme j -Kmt IK o— BmmK —Bn- ir -1 ^ This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 1221772 A7 B7 V. Description of the invention (16) and clinical examination of wounds and arthritis to determine anti-inflammatory activity. The anti-inflammatory effect of some pure egg anti-inflammatory compositions is given by bioassay '/ J. A preferred bioassay is a mouse type 11 gel assay as listed in Example 6. Another bioassay includes pleural leukocyte migration inhibition assays; as contained in the following data: Vinegar et al ,, Some Quantitative Characteristics of Carrageenan Induced Pleurisy in the Rat, `` Proc. Soc. Exp · Bio · Med · 143: 711_714 (1 973), Ammendola, G. et al., &Quot; Leukocyte Migration and Lysozomal Enzymes Release in Rat Carrageenan Pleurisy, &quot; Agents and Actions 5: 250-255 (1975) 'Vinegar, R et al.5 &quot; Printed by the Quantitative Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back before filling this page)

Studies of the Pathway to Acute Carrageenan Inflammation,&quot;Fed· Proc. 35:2447-2456 ( 1 976) 白血球移動抑制檢定為另一種有用的檢定,其通常係依下 述而實施的:將含抗發炎組合物的樣品給經用1 %角叉菜膠 溶液予以人工發炎成雌鼠服用後,經由經處理老鼠的胸膜 泌出物中所含白血球數目相對於對照老鼠數目之減少量測 定(用自動成像分析技術)每一劑量的樣品抗發炎作用。 另外,可在經由注射角叉菜膠於老鼠肉足所引起的水腫上 檢驗實質純抗發炎組合物所具抗發炎作用(Winter,C. A., Risley, G. A. Nuss, A. W., &quot;Carrageenan-Induced Edema in the Hind Paw of the Rat as an assay for anti-Infammatory drugs,” Proc· Soc· Exper. Biol. -19- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公廣) b____ 經濟部中央標準局員工消費合作社印製 A7 __B7_ 發明説明(17 )Studies of the Pathway to Acute Carrageenan Inflammation, &quot; Fed · Proc. 35: 2447-2456 (1 976) White blood cell movement inhibition test is another useful test, which is usually implemented as follows: a combination of anti-inflammatory A sample of the animal was administered to female rats artificially inflamed with a 1% carrageenan solution, and the decrease in the number of white blood cells contained in the pleural exudates of the treated mice relative to the number of control mice was determined (analyzed by automatic imaging) Technique) The anti-inflammatory effect of each dose of the sample. In addition, the anti-inflammatory effect of a substantially pure anti-inflammatory composition can be tested on the edema caused by carrageenan injection in the meat feet of mice (Winter, CA, Risley, GA Nuss, AW, &quot; Carrageenan-Induced Edema in the Hind Paw of the Rat as an assay for anti-Infammatory drugs, "Proc · Soc · Exper. Biol. -19- This paper size applies to China National Standard (CNS) A4 (210X 297 public broadcasting) b____ Central Standard of the Ministry of Economic Affairs A7 __B7_ printed by Bureau of Consumer Cooperatives Invention Description (17)

Med. 3:544( 1 967)) ° 此外也可以使用多種其化的生物檢定(參看W e t n i c k,A. S .,and S abin,C ·,The Effects of Clonixin and B ethaurethasone on Adjuvant-Induced Arthritis and Experimental Allergic Encephalomyelitis in Rats5M Jap. J. Pharm. 22:74 1 ( 1 972))° 部份純化抗發炎組合物之牿料 邵份純化抗發炎組合物具有下列諸特性: ⑴在個體動物體内具有抗發炎活性; ⑵存在於禽卵的卵白和卵黃中; ⑶於從卵黃分離出之後,此從卵白分離出者具有較大的抗 發炎活性; ⑷具有低於約3,0 〇 〇道耳呑之分子量; (〇)為非蛋白質及非類固醇者; (6)具有熱安定性; ⑺具有口服作用性且不會被消化酵素所分解; 3,000迢耳呑分子量係從組合物部份分離和純化所推出 其中該分離純化程序係使用不會讓大於3,〇〇〇道耳呑的 /刀子物種穿透的超濾、膜。經部份純化的抗發炎組合物經測 $係非蛋白質性及非一類固醇性者因其尺寸小且不會被降 解蛋白I的酵素所分解之故。再者,該組合物具口服活性 ^不被消化酵素所降解。小而安定形式的經部份純化抗發 人、卫口物(以與遠較為大的蛋白質區別者)有助於其自消化道 的吸收。取後’該經部份純化抗發炎組合物具有熱安定 1221772 經濟部中央標準局員工消費合作社印製 A7 五、發明説明(18 ) 性。 邵份純化卵源抗發炎組合物可自全卵,卵黃和卵白分離 出。從卵黃部份純化所得抗發炎組合物比從卵白經部份純 化所得抗發炎組合物顯示出較高的抗發炎活性。 本案發明人發現從經超免疫化的產卵動物所生的全卵,印 更和卵白皆可分離出超正常水平的經部份純化抗發炎組合 物。 產卵動物的超免疫化 如剛才所述者,本案發明人發現在超免疫卵中存在著超正 常水平的抗發炎組合物其可提供抗發炎活性給個體動物。 起免疫卵或卵產物可由任何種產卵動物所產生。較佳者該 動物為鳥綱之一員或換言之,一禽。在鳥綱之内,較佳者 為家禽,不過此綱内的其它成員,例如火雞、鴉、和鵝, 也都是適當的超免疫卵產物來源。 在彼等產卵動物經由利用,例如,週期地加強給用免疫原 而帶到一特定的免疫化狀態時,該等動物即產卵,其在給 一個體服用後,具有效益性質,包括超正常水平的抗發炎 組合物,其可以有效地治療和預防該個體動物的發炎相關 疾病以及自體免疫性疾病。 免疫敏感性的謗發單獨者不足以促成在卵中出現超正常水 平的卵源抗發炎組合物,如食用卵不含彼等超正 事實所證明者,即使該禽在對抗禽疾病的正常免疫化中及 在對環境目素的正常暴露巾經針對各種免疫原予以敏化過 也一樣。本案發明人發現只有在料的超免疫狀態中,卵 •21 - 本紙張尺度適用中國國家標準(CNS) M規格(21〇x 297公楚) (請先閲讀背面之注意事項再填寫本頁)Med. 3: 544 (1 967)) ° In addition, a variety of bioassays can be used (see Wetnick, A. S., and S abin, C ·, The Effects of Clonixin and B ethaurethasone on Adjuvant-Induced Arthritis and Experimental Allergic Encephalomyelitis in Rats5M Jap. J. Pharm. 22:74 1 (1 972)) ° Ingredients for partially purified anti-inflammatory compositions. Purified anti-inflammatory compositions have the following characteristics: It has anti-inflammatory activity; ⑵ It is present in the egg white and yolk of avian eggs; ⑶ After isolation from egg yolk, the person isolated from the egg white has greater anti-inflammatory activity; ⑷ has less than about 3,000 channels ear分子量 molecular weight; (0) non-protein and non-steroidal; (6) with thermal stability; 口服 oral effect and will not be broken down by digestive enzymes; 3,000 迢 molecular weight is isolated from the composition part He Purification has introduced an ultrafiltration, membrane in which the separation and purification procedure uses an ultrafiltration, membrane that does not allow greater than 3,000 channels / knife species to penetrate. Partially purified anti-inflammatory compositions have been tested. $ Non-proteinaceous and non-steroidal ones are small in size and cannot be broken down by enzymes that degrade protein I. Furthermore, the composition is orally active and is not degraded by digestive enzymes. A small, stable form of partially purified anti-hair, mouthwash (to distinguish it from larger proteins) helps its absorption from the digestive tract. After removal ’, the partially purified anti-inflammatory composition has thermal stability 1221772 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 V. Description of the invention (18). The Shaofen purified egg-derived anti-inflammatory composition can be isolated from whole eggs, yolk, and egg white. The anti-inflammatory composition obtained from the yolk portion purification showed higher anti-inflammatory activity than the anti-inflammatory composition obtained from the egg whites partial purification. The inventors of the present case have discovered that partially normal purified anti-inflammatory compositions can be isolated from normal eggs and agars from whole eggs produced by hyperimmunized oviparous animals. Hyperimmunization of egg-laying animals As mentioned just now, the inventors of the present case have found that there are ultra-normal levels of anti-inflammatory compositions in hyper-immune eggs that can provide anti-inflammatory activity to individual animals. Immune eggs or egg products can be produced by any species of ovipositor. Preferably, the animal is a member of the Ornithoptera or in other words, a bird. Within the bird class, poultry is preferred, but other members in this class, such as turkeys, crows, and geese, are also suitable sources of hyperimmune egg products. When their oviposition animals are brought to a specific state of immunity through the use of, for example, a periodic booster administration of immunogens, these animals lay their eggs, which have beneficial properties, including A normal level of anti-inflammatory composition that is effective in treating and preventing inflammation-related diseases and autoimmune diseases of the individual animal. Immunosensitivity alone is not sufficient to promote the occurrence of supernormal levels of egg-derived anti-inflammatory compositions in eggs, such as edible eggs that do not contain their super-positive facts, even if the bird is normally immune to bird disease The same is true for sensitization of various immunogens during and during normal exposure to environmental elements. The inventor of this case found that the egg is only in the hyper-immune state of the material. • 21-This paper size applies the Chinese National Standard (CNS) M specification (21〇x 297). (Please read the precautions on the back before filling this page)

1221772 經濟部中央標準局員工消費合作社印製 A7 ______B7五、發明説明(19T^ ^^ &quot; -~~ 才會具有合意的超正常水平之抗發炎組合物。 故種卵會含有較高水平抗發炎組合物的特殊超免疫狀態較 佳者係經由施以起始免疫化,接著用足夠高劑量的特殊免 f原或免疫原混合物週期地加強而達到。加強劑的較佳劑 量必須等於或大於產生該禽初免疫化所需劑量的5〇%。因 此,存在著一加強劑閾劑量,低於此劑量就不能在禽卵中 產生該等性質,即免該禽係在一般稱為免疫狀態中時亦 然。在知道發展及保持超免疫狀態的要求之後,諳於此技 者即可依照所用的產卵動物屬系而變異所施用的免疫原量 以期將該動物保持在超免疫狀態中。 該超免疫狀態較佳者係用任何免疫原或免疫原組合所產生 者。超免疫化較佳者係經由多次暴露於多重免疫原,多次 暴露於單一免疫原,或單次暴露於免疫原庫而達到。幾乎 任何免疫原皆可用來謗發出超免疫狀態,其包括,但不限 於’細菌’病毒,原生動物,過敏原,真菌或細胞物質。 在了解發展和維持超免疫狀態之要求後,諳於此技者即可 根據所用的產卵動物屬系而變異給用的免疫原量以期將動 物維持在超免疫狀態。 除了用天然發生的免疫原進行免疫化之外,也可以用經由 組合化學合成衍生的免疫原完成免疫化。基本策略在於組 t出诸化學組合元件(chemical building block)的多動組 合以產生一群相異性分子。最近已開發出數種方法用於寡 聚物庫(Fodor,S, et al.,Science 25 1:767 ( 1 99 1 ); H〇ughton,R. et al·,Nature 3 54:82 ( 1 99 1 ))以及小有 _ -22- 本紙張尺度適用中國國家標準(CNS)A4規格(210X 297公楚) — (請先閲讀背面之注意事項再填寫本頁) 訂 d ^ ί ΙΒΚ· 1221772 A7 B7 五、發明説明(2〇 ) 機分子 Bunln,B. &amp; EUman,J,J Am Chem sQe 1 14: 1 0997 ( 1 992)的固相與溶液相合式合成。快速的多重 肽和寡聚物合成可用為組合衍生免疫原之來源。再者,另 一策略為,組合方式將有機組合元件添加到骨架分子内以 改良免疫禮。 將產㈣物超免疫化的其它方式可以用來取代免疫原疫苗 且包括基因疫苗的使用。特別者,任何DNA構成物(通常包 括啟動基因區與抗原編碼區)皆可啟動免疫反應。基因疫苗 包括、.二輻送以產生免疫反應的編碼抗原之截體,裸d N A片 段,質體DNA,DNA-RNA抗原,dna-蛋白質拼合物, DNA-脂質體拼合物,DNA表現庫,及病毒與細菌〇财。 DNA輸送方法包括,與其它一起者,粒子撞擊,直接注 射,病毒載體,脂質體與噴射器注射。在使用這些輸送方 法時,可需要遠較為小的量且通常可導致較持續性免疫原 產生。在使用彼等基因法時,將D N A導禽體中的較佳方法 為透過將D N A肌肉注射到胸肌内之方式。1221772 A7 printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. B7 V. Invention Description (19T ^ ^^ &quot;-~~ Only the anti-inflammatory composition with a desirable supernormal level will be obtained. Therefore, the egg will contain a higher level of anti-inflammatory. The particular hyperimmune state of the composition is preferably achieved by administering the initial immunization, followed by periodic strengthening with a sufficiently high dose of a special immunogen or immunogen mixture. The preferred dose of the booster must be equal to or greater than the yield 50% of the dose required for the initial immunization of the bird. Therefore, there is a threshold dose of a booster, below which no such properties can be produced in the eggs of the bird, which means that the bird is in a state generally called immune This is also the case. After knowing the requirements for developing and maintaining a hyperimmune state, those skilled in the art can vary the amount of immunogen applied according to the genera of the oviposition animals used in order to keep the animal in a hyperimmune state. The better hyperimmune state is produced by any immunogen or combination of immunogens. The better hyperimmune state is multiple exposures to multiple immunogens and multiple exposures to a single immunogen Or achieved by a single exposure to an immunogen pool. Almost any immunogen can be used to liberate a hyperimmune state, including, but not limited to, 'bacterial' viruses, protozoa, allergens, fungi, or cellular material. In understanding the development and After the requirement to maintain the hyperimmune state, those skilled in the art can vary the amount of immunogen given according to the genera of the oviposition animals used in order to maintain the animal in the hyperimmune state. In addition to immunization with naturally occurring immunogens In addition, immunogenization can also be accomplished with combinatorial chemistry-derived immunogens. The basic strategy is to create a group of dissimilar molecules by combining multiple movements of chemical building blocks to produce a group of dissimilar molecules. Several species have recently been developed The method is used for the oligomer library (Fodor, S, et al., Science 25 1: 767 (1 99 1); Hughton, R. et al., Nature 3 54:82 (1 99 1)) and small Yes -22- This paper size applies to the Chinese National Standard (CNS) A4 specification (210X 297 Gongchu) — (Please read the precautions on the back before filling this page) Order d ^ ί ΙΒΚ · 1221772 A7 B7 V. Description of the invention (2 ) Organic molecules Bunln, B. &amp; EUman, J, J Am Chem sQe 1 14: 1 0997 (1 992) solid phase and solution phase synthesis. Rapid multiplex peptide and oligomer synthesis can be used as a combination derived immunogen Source. Furthermore, another strategy is to add organic combination elements to the backbone molecule in a combined way to improve the immune system. Other ways to hyperimmunize the product can be used to replace the immunogen vaccine and include the use of gene vaccines. In particular, any DNA construct (usually including a promoter region and an antigen coding region) can initiate an immune response. Gene vaccines include: two antigen-encoding fragments that are radiated to generate an immune response, naked d NA fragments, plastid DNA, DNA-RNA antigens, dna-protein complexes, DNA-liposome complexes, DNA expression libraries, And viruses and bacteria. DNA delivery methods include, among others, particle impingement, direct injection, viral vectors, liposomes and ejectors. When using these delivery methods, much smaller amounts can be required and can often result in more sustained immunogen production. When using their genetic method, the preferred method for introducing DNA into birds is by injecting DNA muscle into the pectoral muscle.

DNA輸送方法包括,但不限於,粒子撞擊,直接注射, 脂質體’噴射器注射(Fynan,E F et al,Pr〇c NaU 經濟部中央標準局員工消費合作社印製DNA delivery methods include, but are not limited to, particle impingement, direct injection, liposome ’ejector injection (Fynan, E F et al, Proc NaU, printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

Acad. Sen. USA 90: 1 1478- 1 1482 ( 1 993))。編碼已知或 未知免疫原,啟動基因(值得注意者CMV花椰菜花葉病毒) 和S V40細菌原之核酸可在細菌體内複製產生質體DN a供 DNA〉王射所用。雖然有數種非經腸給用DNA的途徑在難體 内有效,不過較佳的方法仍為肌肉内注射到胸肌内。在產 卵禽類,較佳者難中進行疫苗試驗。在長達6個月期間以一 -23- 本紙張尺度適用中國國家標準(CNS ) A4規格------ 1221772 A7 B7 五、發明説明(21 ) 至二週間隔施以重複地免疫化處理。 較佳的DNA用量通常是在50-3 00微克DNA/直接注射用 食鹽水之級次。用於粒子撞擊時,較佳者為4_1〇〇微克經於 添加2 · 5 M C a C12而共沈炎到金珠粒上之d n A。用這種加速 徑D N A塗被粒子進入活動物體内的方法可以經由皮内實施 重複免疫化。 下面為用來將產卵動物帶到高免疫狀態使所得超免疫化卵 或卵產物可給一個體動物服用的較佳程序之詳細說明: 1. 選擇一或多種免疫原。 2. 經由初免疫化謗發產卵動物的免疫反應。 3·給用恰當劑量的免疫原加強疫苗以誘導和保持超免疫狀 態。 4·檢驗超免疫卵所具抗發炎活性水平。 5·收集和處理該卵。 下文為此程序的更詳細說明 步驟1 : 經濟部中央標準局員工消費合作社印製 任何免疫原或免疫原組合都可用為疫苗。該等疫苗可為產 卵動物所具免疫系統會反應之細菌,病毒,原生動物,真 菌’細胞,或任何其它物質。此步驟中的關鍵點在於該免 疫原必須能夠在產卵動物體内產生免疫及超免疫狀態。雖 然只有單一免疫原也可作為本發明方法的疫苗,不過一種 較佳疫苗為選自下列抗原族的多價細菌和病毒抗原:腸桿 菌和擬桿菌,肺炎球菌,假單胞菌,沙門氏菌,鏈球菌, 桿菌,葡萄球菌,奈瑟氏球菌,梭菌,分枝桿菌,放線 -24- ^紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ' &quot; 122 72 經濟部中央標準局員工消費合作社印製 A7 _____B7 ___ 五、發明説明(22 ) 菌’衣原體’和枝原體。病毒抗原較佳者為選自下列抗原 族者:腺病毒,微小核糖核酸病毒,和疱疹病毒,不過其 它病毒抗原族也可以用。 於一較佳實施例中,係使用稱為Series 100(s_10〇)的多 價疫苗。S - 1 0 〇疫苗中所包括的細菌列於實施例1的表1之 中。此種疫苗已在先前於美國專利第5,1〇6,618和 5,2 1 5,7 4 6號中敘述過,這兩專利皆經讓渡給s t 〇 i j eAcad. Sen. USA 90: 1 1478- 1 1482 (1 993)). Nucleic acids encoding known or unknown immunogens, promoter genes (noticeable CMV cauliflower mosaic virus) and S V40 bacterial protozoa can be replicated in bacteria to produce plastid DN a for DNA> Wang She. Although several parenteral routes of DNA administration are effective in difficult bodies, the preferred method is intramuscular injection into the pectoral muscles. Vaccine testing is more difficult in spawning birds. During the period of up to 6 months, the standard of China Paper (CNS) A4 is applicable to this paper size --- 1221772 A7 B7 V. Description of the invention (21) Repeated immunization at intervals of two weeks deal with. The preferred amount of DNA is usually in the range of 50 to 300 micrograms of DNA per saline for direct injection. For particle impaction, it is preferred that d n A is co-sedimented to gold beads by adding 4 to 100 micrograms after adding 2.5 M C a C12. This method of accelerating the coated particles with a diameter of D N A into a moving object can be repeated by intradermal immunization. The following is a detailed description of a preferred procedure for bringing the oviposition animal to a highly immune state so that the resulting hyperimmune egg or egg product can be administered to a single animal: 1. Select one or more immunogens. 2. Immune response of spawning animals through primary immunization. 3. Promote a proper dose of immunogen booster vaccine to induce and maintain a hyperimmune state. 4. Check the level of anti-inflammatory activity of hyperimmune eggs. 5. Collect and dispose of the eggs. Below is a more detailed description of this procedure. Step 1: Printed by the Consumer Cooperative of the Central Standards Bureau, Ministry of Economic Affairs. Any immunogen or combination of immunogens can be used as a vaccine. These vaccines can be bacteria, viruses, protozoa, fungus' cells, or any other substance that the immune system of the spawning animal responds to. The key point in this step is that the immunogen must be able to generate immune and hyperimmune states in the egg-laying animal. Although only a single immunogen can be used as a vaccine in the method of the present invention, a preferred vaccine is a multivalent bacterial and viral antigen selected from the following antigen families: Enterobacteria and Bacteroides, Pneumococcus, Pseudomonas, Salmonella, Streptomyces Cocci, Bacillus, Staphylococcus, Neisseria, Clostridium, Mycobacteria, Actinomycetes -24- ^ Paper size applies to China National Standard (CNS) A4 (210X297 mm) '&quot; 122 72 Central Bureau of Standards, Ministry of Economic Affairs A7 printed by employee consumer cooperatives _____B7 ___ V. Description of the invention (22) Bacteria 'Chlamydia' and Mycoplasma. Viral antigens are preferably selected from the following antigen families: adenovirus, picornavirus, and herpes virus, although other viral antigen families can also be used. In a preferred embodiment, a multivalent vaccine called Series 100 (s_100) is used. Bacteria included in the S-100 vaccine are listed in Table 1 of Example 1. Such vaccines have been previously described in U.S. Patent Nos. 5,106,618 and 5,21,576,46, both of which have been assigned to st 0 i j e

Research and Development Corporation。 步驟2 :Research and Development Corporation. Step 2:

遠疫句可為經殺死或經減弱活力的疫苗且可以用能謗發免 疫反應的任何方法施用。較佳者,該免疫化係經由肌肉内 注射施用免疫原而完成的。禽體供注射的較佳肌肉為胸 肌。其劑量較佳者為0.05 _5毫克的免疫原性疫苗。可以使 用的其它施用方法包括靜脈内注射,腹膜内注射,皮内, 直腸栓藥,氣霧劑,經口,局部或經眼施藥。在使用DN A 技術於超免疫化程序時,需要遠較為小的量,通常為3〇〇微 克。 边過卉多種具有免疫學技藝者所知的方法可以測定疫苗是 否謗發出產卵動物體内的免疫反應。彼等方法的例子包括 酵素聯結免疫吸著劑檢定(ELISA),針對刺激性抗原的抗 體4存在檢驗,及設計用來評估宿主免疫細胞所具對抗原 產生反應的能力之檢驗。謗發免疫反應所需的最小抗原劑 量決足於所用的接種程序,包括所用佐劑與抗原調配物之 類別以及用為宿主的產卵動物之類別。 (請先閱讀背面之注意事項再填寫本頁)The distant epidemic can be a killed or weakened vaccine and can be administered by any method that can shed an immune response. Preferably, the immunization is performed by intramuscular injection of an immunogen. The preferred muscle for poultry injection is the pectoral muscle. The preferred dose is 0.05-5 mg of immunogenic vaccine. Other methods of administration that can be used include intravenous injection, intraperitoneal injection, intradermal, rectal suppositories, aerosols, oral, topical or ocular administration. When using DNA technology for hyperimmunization procedures, much smaller quantities are required, typically 300 micrograms. Bian Guohui has a variety of methods known to those skilled in immunology to determine whether the vaccine sheds an immune response in the oviposition animal. Examples of these methods include enzyme-linked immunosorbent assay (ELISA), antibody 4 presence test for stimulating antigens, and tests designed to assess the ability of host immune cells to respond to the antigen. The minimum amount of antigen required to defy the immune response will depend on the vaccination procedure used, including the type of adjuvant and antigen formulation used and the type of oviposition animal used as the host. (Please read the notes on the back before filling this page)

-25--25-

1221772 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(23 ) 步驟3 : 超免疫狀態較佳者係經由於固定時間間隔重複加強施用恰 當劑量而於標的動物體内謗導出且予以保持住;該時間間 隔較佳者為在6 -1 2個月期間的2 - 8週間隔。不過,重要者為 該為加強劑施用不會導致免疫耐受性。彼等方法皆為技藝 中熟知者。 可以採用其它的免疫化維持程序或程序組合,例如,用肌 肉内注射於初免疫化且用靜脈内注射於加強劑注射。其它 紅序包括同時施用微包封型和液體型抗原,或肌肉内注射 進行初免疫化,及經由口服或經由微包封手段非經腸施用 進行加強劑投藥。初免疫化和超免疫化的數種組合皆為諳 於此技者所知者。 步騾4 : 有需要檢驗卵所具抗發炎活性水平。此可經由檢驗超免疫 卵,或其衍生產物對發炎的影響之任何臨床和臨床前評估 予以完成。老鼠的化學謗導發炎為抗發炎藥物的較佳標準 檢定(參看實施例6 )。 步騾5 : 此步驟包括含有抗發炎組合物的卵之收集和處理。卵可經 由習用方法來收集。卵的處理可用本文件後文所述多種方 式予以完成。卵也可以經進一步處理以純化下文所述抗發 炎組合物。 t工與施藥 從超免疫動物收集到的卵或其部份物,包括經部份純化的 -26 本纸張尺度適用中國國家標準(CNS ) A4規格(21〇&gt;&lt;297公釐) (請先閲讀背面之注意事項再填寫本頁) 訂 -n· f j tiH— m A7 ------ ----B7 五、發明説明(24 ) 抗發炎組合物,最好再經加工以產生超免疫卵產生物,其 可於隨後給個體動物服用。 即本身或其。P伤體’包括本發明經部份純化的抗發炎組合 物係以治療或預防個體動物發炎,包括關節炎,及/或自體 免疫疾病的任何手段給個體動物服用。較佳者係將卵或卵 的任何衍生物直接飼餵個體動物。重要者為要注意全印, 卵黃,和卵白皆為無毒且安全的天然食品成分。 '另貝施例中’係將卵或其任何部份體,包括經部份純 化的抗發炎組合物,整合到營養補品内。要摻加到營養補 口。中的卵或其任何部份物之一種較佳製備方法包括將卵乾 埏成卵粉。雖則已知有多種方法可用來乾燥卵,不過喷霧 乾爍仍為一種較佳的方法。噴霧乾燥印的程序係技藝中熟 知者。 彼等經乾燥的蛋粉可用,例如,蛋白質粉末,活力飲料, 虫白g補品和任何其它營養,運動相關性產品之形式摻加 到飲料内。此外,蛋粉可以用於烘焙混料,活力棒,糖 果,餅乾等之中。卵加工的其它例子包括製成煎蛋捲,軟 煮或硬煮卵,烘蛋,或,需要時,生吃卵或加工成液態 卵。 最後’進一步分離純化’如經部份純化抗發炎組合物的情 況者,可用於其它給用方式例如非經腸地,皮下,靜脈 内’肌肉内,腹膜内,經鼻内,經口或局部地給用卵產 物。此外’彼等進一步分離可促成用該卵或其部份物製造 包封產品及醫藥組合物。 -27- 本紙張尺度適用中國國家標準(CNs ) A4規格(210X 297公釐) 1221772 五、發明説明(a ) 腸:藥所用抗發炎組合物的製劑包 或 水性洛;夜,懸浮液劣 二醇,聚乙二醇,植^ 水性溶劑或使藥的例子為丙 如油酸乙酯。 ,列如橄欖油和可注射的有機酯例 包抗發炎組合物時’較佳者係經由固體劑形 、人m + 丸J,政劑和粒劑等完成經口給用。 =_中,抗發炎组合物係與至少-種惰性稀釋劑例 作糖或'殿粉相混合。彼等劑形也可包括,如-般 :業中者,惰性稀釋劑以外的添加物質。於膠囊劑,錠 劑,和丸劑的情況中,嗲箬十 ’ 及寺剑形也可包括緩衝劑,pH敏咸 性聚合物,或任何並仑绾鏜P敏感 … 〃匕”皮釋性包封劑其係在食品和藥物工 業中典型地用為包封組合物者。錠劑和丸劑可另外用腸衣 製備成。 ,供經口給用的抗發炎組合物液體卿包括醫藥可接受的乳 液’溶液’懸浮液,糖漿和触劑,其含有醫藥技藝中常用 的惰性稀釋劑。除了惰性稀釋劑之外,組合物也可包括逵 潤劑,乳化劑,懸浮劑,與甜味劑。 土 經濟部中央標準局員工消費合作社印製 本發明超免疫卵或卵產物,包括部份純化的抗發炎組合物 可以有效地治療和預防發炎,且特別是,所有形式的:節 炎,包括,但不限於,風溼性關節炎,骨關節炎,關節黏 連性血清陰性脊椎病,反應性關節炎,慢性疲乏徵候群, 纖維性肌痛(纖維織炎)和痛風^本發明印產物同樣可以有效 地治療自體免疫性疾病,例如風溼性關節炎,幼稚型糖尿 病’複發性硬化症,Gravts氏症,Meneri氏症,重症肌 -28- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) A7 B7 五 發明説明(26 ) 無力’紅《瘡皮癬,系統性硬皮症,風以 SJ〇gren徵候群等(參看本文件,,背景”段卜 …、 在要用來治療與預防_祛姓 特殊疾揭,不論其為一般發炎或關 即炎或自體免㈣疾病形式,之時,該超免㈣產物或其 任何活刀&amp;,包括經部份純化的抗發炎組合物,較佳 μ 4 ±可u有效地治療和預防該特別疾病 給個體動物服用。# ^ ^ 。療的持績期和強度決定於特殊病況, 不雨其疋否存在,且若存在時,在個體動物體内的病況進 展。这超免疫卵屋物或其任何部份物,包括經部份純化的 抗發炎組合物也可以用可治療及,或預防病況和病況徵候 〈任何里|疋i、。你j如,於某些情況中,依$況的特別情勢 而定可以給個體動物服用從少於一全超免疫卵至數個全超 免疫印(或含有相當於少於—個至數個全超免疫_的超免疫 即產物)範圍之每日劑量。經由本文所述方法及技藝中已知 的其匕方法可以分離和濃縮更強力的部份物。 療 於 關 前 於-實施例中,本發明卵產物及經部份純化的抗發炎組合 物經使用膠原誘發關節炎動物模型而發現可以有效地治 老鼠的風溼性關節炎(參看實施例2)。這種動物模型是ς 此技者所公認為相當於人類風溼性關節炎效果者。除了曰 節炎的治療之外,亦經測定該卵產物於謗導出關節炎之則 給老鼠服用時,可延缓且於某些情況中,可預防關節炎徵 候的起始。因此,本發明卵產物不僅可以有效地治療疾病 徵候,而且可延緩及/或預防疾病的起始或進展。 於另一貫施例中,係在人體中檢驗卵產物且證明在數個患 -29- 1221772 A7 B7 五、發明説明(27 ) 請 先 閱 讀 背 5 i 事 項 再 填麄 有關節炎徵候的人體有正面的治療各種形式關節炎之效用 (參看實施例9)。用該卵產物治療過的人展現出除了腫脹與 僵硬的一般減輕外之徵候如疼痛的臨床減低。 對自體免疫性疾病的效應顯示為本發明卵產物以及經部份 純化抗發炎組合物對第II型膠原抗體的令人訝異之減少,此 亦在老鼠體内看到(參看貫施例3 )。本發明印產物預期可以 有效地減少涉及其它自體免疫性疾病之抗體;例如幼稚型 糖尿病,複發性硬化症,Graves氏症,Meneri氏症,重症 肌無力,紅斑狼瘡,牛皮癬,系統性硬皮症,風溼熱和 Sjogren徵候群等。 訂 如發明背景中所述者,關節炎患者目前係經非-類固醇類 抗發炎藥物(NS AIDs)及/或疾病調節性抗關節炎藥物 (DMARDs)予以治療以解關節炎病況的徵候。如實施例 中所示者(參看實施例9)患者可於現行藥物治療下同時給用 本發明卵產物。卵產物可與藥物治療協同地作用而減輕特 殊疾病的徵候。所以卵產物可與另外的治療同時地施用以 對抗關節炎和自體免疫性疾病而產生協同地更佳效果。 經濟部中央標準局員工消費合作社印製 此外,技藝中熟知者,NS AIDs和DMARDs可能引起嚴 重的胃腸傷害。讓渡給DCV,Inc·,且併於本文作為參考的 美國專利第5,7 7 2,9 9 9號揭示出超免疫卵產物可以有效地治 療In S AI D - έ秀導之胃腸傷害。所以,另一實施例預期可用於 個體動物正接受或預備接受NSAIDs以治療關節炎病況之情 況。於彼等情況中,該個體動物也可以服用本發明卵產物 以期不僅治療關節炎病況,而且保護胃腸系統免於受到 -30- 本纸張尺度適用中國國家標準(CNS )八4規格(21〇χ 297公釐 1221772 五 經濟部中央標準局員工消費合作社印製 A7 B7 發明説明(28 N S AID p秀導傷害。於彼等治療中,較低劑量的超免疫卵可 能即足夠所用。此外,患有該疾病的個體動物可在其開始 接雙NSAIDs和DMARDs投藥之前即服用卵產物以期更佳 地備好胃腸系統。 可經由服用本發明卵,卵產物,及/或抗發炎組合物予以 /口療的發炎病況例子包括急性和亞急性黏液囊炎,急性非 特異性腱炎,系統性紅斑狼瘡,系統性皮肌炎,急性風澄 ^ ^ ^ 天癌瘡’大癌皮炎,疱療狀炎,嚴重發紅,多形 式脫落性皮炎,硬變,季節性常年鼻炎,支氣管喘哮,異 ^性皮炎,血清病,角膜炎,眼虹膜炎,瀰漫性ureitls, 聲τ炎’視神經炎,交感性眼炎,徵狀性肉狀瘤病,1221772 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (23) Step 3: Those with better hyperimmunity status are defamated in the target animal by repeatedly intensifying the application of the appropriate dose at fixed intervals Keep it; this time interval is preferably between 2 and 8 weeks between 6 and 12 months. However, it is important that booster administration does not lead to immune tolerance. Both methods are well known in the art. Other immunological maintenance procedures or combinations of procedures can be used, for example, intramuscular injection for primary immunization and intravenous injection for booster injection. Other red sequences include simultaneous administration of microencapsulated and liquid antigens, or primary immunization by intramuscular injection, and booster administration via oral or parenteral administration via microencapsulation. Several combinations of primary and hyperimmunization are known to those skilled in the art. Step 4: It is necessary to test the level of anti-inflammatory activity of eggs. This can be done by any clinical and preclinical assessment of the effects of hyperimmune eggs, or derivatives thereof, on inflammation. Inflammation induced by chemical slander in mice is a better standard test for anti-inflammatory drugs (see Example 6). Step 5: This step involves the collection and treatment of eggs containing an anti-inflammatory composition. Eggs can be collected by conventional methods. Egg treatment can be accomplished in a number of ways as described later in this document. Eggs can also be further processed to purify the anti-inflammatory composition described below. Eggs or parts thereof collected from hyperimmune animals, including partially purified -26. This paper is in accordance with the Chinese National Standard (CNS) A4 specification (21〇 &gt; &lt; 297 mm). ) (Please read the precautions on the back before filling this page) Order -n · fj tiH— m A7 ------ ---- B7 V. Description of the invention (24) Anti-inflammatory composition, it is best to Processed to produce a hyperimmune egg spawn that can be subsequently administered to an individual animal. Ie itself or it. Injury body 'includes the partially purified anti-inflammatory composition of the present invention for administration to an individual animal by any means for treating or preventing inflammation, including arthritis, and / or autoimmune disease in an individual animal. Preferably, the egg or any derivative of the egg is directly fed to the individual animal. It is important to note that All India, Yolk, and Egg White are non-toxic and safe natural food ingredients. In another embodiment, the egg or any part thereof, including a partially purified anti-inflammatory composition, is integrated into a nutritional supplement. To be added to the nutritional supplement. A preferred method of preparing the eggs or any part thereof includes scavenging the eggs into egg powder. Although several methods are known for drying eggs, spray drying is still a preferred method. The process of spray drying is known in the art. Their dried egg powders can be incorporated into beverages in the form of, for example, protein powders, energy drinks, insect white supplements and any other nutritional, sports related products. In addition, egg powder can be used in baking mixes, vitality bars, candies, biscuits, etc. Other examples of egg processing include making omelettes, soft-boiled or hard-boiled eggs, baking eggs, or, if needed, raw eggs or processing into liquid eggs. Finally, 'further isolation and purification', as in the case of partially purified anti-inflammatory compositions, can be used for other administration methods such as parenteral, subcutaneous, intravenous' intramuscular, intraperitoneal, intranasal, oral or topical Give egg products to ground. In addition, 'their further separation may facilitate the production of encapsulated products and pharmaceutical compositions using the eggs or parts thereof. -27- This paper size is in accordance with Chinese National Standards (CNs) A4 (210X 297 mm) 1221772 V. Description of the invention (a) Intestine: anti-inflammatory composition preparation package or water-based drug; night, suspension is inferior Examples of alcohols, polyethylene glycols, aqueous solvents or drugs are propionate such as ethyl oleate. For example, in the case of olive oil and injectable organic esters, when the anti-inflammatory composition is packaged, it is preferred to perform oral administration via solid dosage form, human m + pills J, government agents and granules. = _, The anti-inflammatory composition is mixed with at least one inert diluent, such as sugar or dian powder. Their dosage forms may also include, for example, those in the industry, in addition to inert diluents. In the case of capsules, lozenges, and pills, 嗲 箬 Shi 'and Temple shape can also include buffering agents, pH-sensitive salty polymers, or any combination of Pycnogenol and P-sensitive ... Encapsulants are those typically used as encapsulating compositions in the food and pharmaceutical industries. Lozenges and pills can be additionally prepared with enteric coatings. Anti-inflammatory compositions for oral administration Liquids include pharmaceutically acceptable emulsions 'Solution' suspensions, syrups and tentacles, which contain inert diluents commonly used in medical technology. In addition to inert diluents, the composition may also include wetting agents, emulsifying agents, suspending agents, and sweeteners. The Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs printed the hyperimmune eggs or egg products of the present invention, including partially purified anti-inflammatory compositions, which can effectively treat and prevent inflammation, and in particular, all forms of: arthritis, including, but Not limited to rheumatoid arthritis, osteoarthritis, joint adhesion seronegative spondylosis, reactive arthritis, chronic fatigue syndrome, fibromyalgia (fibritis) and gout ^ The printed products of the present invention are the same Can effectively treat autoimmune diseases, such as rheumatoid arthritis, juvenile diabetes' relapsing sclerosis, Gravts's disease, Meneri's disease, myasthenia. 28- This paper standard applies to China National Standard (CNS) A4 (210X 297 mm) A7 B7 Five invention descriptions (26) Weakness' red "Sore itch, systemic scleroderma, wind and SJogren syndrome, etc. (see this document, background" paragraph bu ... Used for the treatment and prevention of special diseases, whether it is general inflammation or immediate inflammation or autoimmune diseases, at the time, the super immune products or any live knife &amp; including partial purification The anti-inflammatory composition, preferably μ 4 ±, can effectively treat and prevent this particular disease to individual animals. # ^ ^. The duration and intensity of the treatment depends on the particular condition, whether it exists or not, and If present, the condition progresses in the individual animal. This hyperimmune egg house or any part thereof, including partially purified anti-inflammatory compositions, can also be used to treat and / or prevent conditions and symptoms < Anywhere | 疋 i ,. For example, in some cases, depending on the particular situation of the situation, individual animals can be administered from less than one full hyperimmune egg to several full hyperimmune imprints (or containing less than one to several Daily doses in the range of full hyperimmune (hyperimmune, i.e. product). The more powerful fractions can be separated and concentrated by the methods described in this article and their techniques known in the art. The egg product of the present invention and the partially purified anti-inflammatory composition were found to be effective in treating rheumatoid arthritis in mice by using an animal model of collagen-induced arthritis (see Example 2). This animal model is It is considered to be equivalent to the effect of rheumatoid arthritis in humans. In addition to the treatment of arthritis, it has also been determined that the egg product can be delayed and given to mice when it is deduced for arthritis, and in some cases, Prevents the onset of arthritis symptoms. Therefore, the egg product of the present invention can not only effectively treat disease symptoms, but also delay and / or prevent the onset or progression of diseases. In another embodiment, the egg product is tested in the human body and proved to be affected by several -29- 1221772 A7 B7 V. Description of the invention (27) Please read the 5th item before filling in the body with signs of arthritis. Positive effects for treating various forms of arthritis (see Example 9). A person treated with the egg product exhibits clinical reductions in symptoms such as pain in addition to the general reduction in swelling and stiffness. The effect on autoimmune diseases is shown by the surprising reduction of the egg product of the invention and the partially purified anti-inflammatory composition against type II collagen antibodies, which is also seen in mice (see the Examples) 3). The printed product of the present invention is expected to effectively reduce antibodies involved in other autoimmune diseases; for example, juvenile diabetes, relapsing sclerosis, Graves' disease, Meneri's disease, myasthenia gravis, lupus erythematosus, psoriasis, systemic crust Disease, rheumatic fever and Sjogren syndrome. As stated in the background of the invention, arthritis patients are currently treated with non-steroidal anti-inflammatory drugs (NS AIDs) and / or disease-modulating anti-arthritis drugs (DMARDs) to resolve the symptoms of arthritis conditions. As shown in the example (see Example 9), the patient can administer the egg product of the present invention simultaneously under the current drug treatment. Egg products work synergistically with medications to reduce the symptoms of specific diseases. So egg products can be administered simultaneously with additional treatments to produce synergistically better results against arthritis and autoimmune diseases. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs In addition, as is well known in the art, NS AIDs and DMARDs can cause severe gastrointestinal injuries. U.S. Patent No. 5,7,72,9,99, assigned to DCV, Inc., and incorporated herein by reference, discloses that hyperimmune egg products can effectively treat gastrointestinal injuries caused by InS AI D-derivation. Therefore, another embodiment is expected to be useful in situations where an individual animal is receiving or preparing to receive NSAIDs to treat an arthritic condition. In their case, the individual animal can also take the egg product of the present invention in order to not only treat the condition of arthritis, but also protect the gastrointestinal system from -30- This paper standard is applicable to the Chinese National Standard (CNS) 8-4 specification (21〇 χ 297 mm 1221772 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (28 NS AID p show injury. In their treatment, lower doses of hyperimmune eggs may be sufficient. In addition, patients suffering from Individual animals with this disease can take egg products before they start to administer dual NSAIDs and DMARDs to better prepare the gastrointestinal system. They can be administered / orally by taking the eggs, egg products, and / or anti-inflammatory compositions of the invention Examples of inflammatory conditions treated include acute and subacute mucocystitis, acute non-specific tendinitis, systemic lupus erythematosus, systemic dermatomyositis, acute Fengcheng ^ ^ ^ sky cancer sore 'large cancer dermatitis, herpes stigmatitis , Severe redness, multiple forms of exfoliative dermatitis, sclerosis, seasonal perennial rhinitis, bronchial asthma, atopic dermatitis, serum disease, keratitis, eye iritis, diffuse ureitls, Acoustic inflammation ’optic neuritis, sympathetic ophthalmitis, symptomatic sarcoidosis,

Loeffler s氏徵候群,吸入鈹粉所致慢性肺炎,溶血性貧血 症,礼腺炎,乳哭炎,接觸性皮炎,過敏性結合膜炎,牛 皮癬f生關節关’關節黏連性脊椎炎,急性痛風關節炎,帶 狀疱疹性風滢關節1,骨關節炎,任何其它變性關節病, 及任何其它相關的自體免疫性疾病。再者,經分離純化的 卵產物可用來治療暴露於潛在發炎劑例如過敏劑之個體。 有效量 茳 有關:超免疫卵或卵產物給個體動物服用方面,經測定且 在下面F施例中詳述者為,要給個體動物服用的超免疫卵 或卵產物較佳劑量範圍係在i⑼毫克至1〇克每公斤個物 體重之間。 有關經部份純化的抗發炎組合物本身’經敎出該經部份 純化組合物’包括從超免疫卵或卵的全卵,卵黃和卵白純 -31 - 刀離出者,其較佳劑量範圍為i亳克至4 〇 〇毫克抗發炎組 合物每公斤體重之間。 /活性成分的劑量可以變異;不過,必要者為活性成分的量 肩為可仔到適當劑形纟。經公認纟,所選劑形係決定於所 欲治療效用,給藥途徑及治療持續期。 本發月的有利性質可參看下面關明本發明的實施例而觀察 出。 實施例 貫施例1 Uoo疫苗之 一將在美國專利第5,2 1 5,746號中揭示出且含有表}所列細 囷,稱為’,系列100”或” S_100,,的多價疫苗(得自theLoeffler's syndrome, chronic pneumonia caused by inhalation of beryllium powder, hemolytic anemia, rheumatitis, mastitis, contact dermatitis, allergic combined meningitis, psoriasis, and joint adhesion spondylitis, Acute gouty arthritis, herpes zoster rheumatic joint 1, osteoarthritis, any other degenerative joint disease, and any other related autoimmune disease. Furthermore, isolated and purified egg products can be used to treat individuals exposed to potentially inflammatory agents such as allergic agents. The effective amount is related to the administration of a hyperimmune egg or egg product to an individual animal. According to the determination and detailed in the following F examples, the preferred dosage range of the hyperimmune egg or egg product to be administered to an individual animal is i. Between milligrams and 10 grams per kilogram of body weight. With regard to the partially purified anti-inflammatory composition itself, the "partially purified composition" has been extracted from whole eggs, whole yolks, egg yolks, and egg whites of pure-31-knife, the preferred dosage The range is from 1 g to 400 mg of anti-inflammatory composition per kilogram of body weight. The dosage of the active ingredient can vary; however, if necessary, the amount of the active ingredient should be adjusted to the appropriate dosage form. It is generally accepted that the formulation chosen will depend on the desired therapeutic effect, route of administration and duration of treatment. The advantageous properties of this month can be observed with reference to the following examples of the present invention. Examples Example 1 One of the Uoo vaccines will be disclosed in U.S. Patent No. 5,2 1 5,746 and contains the detailed list listed in the table, referred to as ', series 100' or 'S_100,' a multivalent vaccine ( From the

Amenean Type Culture Collection)與 15 毫升培養基重 凋並在37。(3下培育整個晚上。在獲得良好生長後,用約一 ,的、、田菌懸浮液接種一升肉湯(b r 〇 t h),再於3 7 °C下培育。 剩餘懸浮液則轉移到無菌二醇管内並貯存在_ 2 〇 I下長達6 個月。 經濟部中央標準局員工消費合作社印製 在培養液中可看到良好生長之後,離心收取細菌。將細菌 丸再懸浮於無菌生理食鹽水溶液内並將細菌樣品離心,三 次以洗清細菌。於第三次清洗之後,將所得丸再懸浮於少 量雙重蒸餾水中。 將無培養基的細菌懸浮液置於玻璃燒瓶内並放在8 〇艽水 浴中個晚上以加熱殺死該懸浮液。用少量經熱殺的細菌 檢驗肉湯培養物的存活性。用該經熱殺的細菌接種肉湯, -32- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇χ 297公釐) 1221772 A7 B7 五、發明說明(30 ) 在3 7 °C下培育5天且每天檢查其生長,因該細菌必須經殺死 供疫苗所用之故。 將經熱殺死的細菌冷凍乾燥。然後將乾細菌與無菌食鹽水 溶液混合到2 · 2 X 1 08細菌細胞/毫升食鹽水之濃度(丨.〇 660 nm光密度讀值)。 表1 S - 1 0 0疫苗中的抗原Amenean Type Culture Collection) with 15 ml of culture medium and reconstituted at 37 ° C. (Incubate at 3 times throughout the night. After good growth is obtained, inoculate one liter of broth with broth suspension of broth, and incubate at 37 ° C. The remaining suspension is transferred to Sterile diol tube and stored under _ 2OI for up to 6 months. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. After seeing good growth in the culture medium, centrifuge to collect the bacteria. Resuspend the bacterial pellets in the sterile The bacterial sample was centrifuged in a physiological saline solution, and the bacteria were washed three times. After the third washing, the resulting pellet was resuspended in a small amount of double distilled water. The culture-free bacterial suspension was placed in a glass flask and placed in 8 〇The suspension was killed by heating in a water bath overnight. The viability of the broth culture was tested with a small amount of heat-killed bacteria. The heat-killed bacteria were used to inoculate the broth, -32- Standard (CNS) A4 specification (21〇χ 297 mm) 1221772 A7 B7 V. Description of invention (30) Incubate at 37 ° C for 5 days and check its growth every day, because the bacteria must be killed for vaccine use Therefore. Will The heat-killed bacteria are freeze-dried. Then dry bacteria and sterile saline solution are mixed to a concentration of 2 · 2 X 10 08 bacteria cells / ml of saline (丨 660 nm optical density reading). Table 1 S-1 0 0 Antigens in vaccines

名 稱 培養基 名 稱 培養基 Staphylococcus simulans BHI 銅綠假單胞菌 (Pseudomonas aerudnosa、 BHI 表皮葡萄球菌 (Staphylococcus epidermidis) BHI 肺炎克雷伯氏菌 (Klebsiella pneumoniae^ BHI _ 膿#玫菌(Streptococcus Dvoeenes), A Types 1 APT 鼠傷寒沙門氏菌 (Salmonella tvphimurium') BHI 釀膿# 珑菌 ^Streptococcus Dvoeenes), A Types 3 APT 豬流感嗜血菌 (HaemoDhilus influenzae) BHI 膿鐘球菌(Streptococcus Dvoeenes), A Types 5 APT 緩症鏈球菌(Streptococcus mitis、 APT 釀膿鐘球菌〔Streptococcus pyogenes), A Types 8 APT 普通變形菌(Proteus vulearis) BHI 酉農膿键球菌(Streptococcus Dvoeenes), A Types 12 APT 病疾志贺氏菌iShkella dvsenteriae) BHI 釀膜鐘球菌(Streptococcus APT 肺炎雙球菌(Diplococcus APT pvogenesl A Tvpes 14 Dneumoniae) S農膿鍵球菌(Streptococcus pyogenesl ATvpes 18 APT 瘡皰丙酸桿菌 iProDionibacter acnes) 肉湯 釀膿鍵球菌(Streptococcus pvogenesV A Types 22 APT 血鐘 5装菌(Streptococcus saneuis) APT 大腸氣桿菌(Aerobacter £〇li) BHI 4 途# 球菌(Streptococcus salivarus) APT 大腸桿菌(Escherichia coif) BHI Streptocccus mutans BHI 經濟部中夬標準局員工消費合作、社印製 (請先閱讀背面之注意事項再填寫本頁) -33- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 1221772 A7 五、發明説明( 31Name Medium Name Medium Staphylococcus simulans BHI Pseudomonas aerudnosa, BHI Staphylococcus epidermidis BHI Klebsiella pneumoniae ^ BHI _ Pus # Streptococcus Dvoeenes, Salmonella typhimurium (Salmonella tvphimurium ') BHI brewing pus # Streptococcus Dvoeenes), A Types 3 APT HaemoDhilus influenzae BHI Streptococcus Dvoeenes, A Types 5 APT Streptococcus Streptococcus mitis, APT Streptococcus pyogenes, A Types 8 APT Proteus vulearis BHI Streptococcus Dvoeenes, A Types 12 APT Shigella iShkella dvsenteriae BHI Streptococcus APT pneumococcus (Diplococcus APT pvogenesl A Tvpes 14 Dneumoniae) Streptococcus pyogenesl ATvpes 18 APT iProDionibacter acnes type broth APT Streptococcus saneuis APT Aerobacter £ 〇li BHI 4 way # Streptococcus salivarus APT Escherichia coif BHI Streptocccus mutans BHI Printed by the company (please read the precautions on the back before filling this page) -33- This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) 1221772 A7 V. Description of Invention (31

經濟部中央標準局員工消費合作社印製 依上文所述製備殺死的病原製備物。用於第_次疫苗接種 時,係將細菌與完全Freund,s氏佐劑混合,並將5 6克細菌 物質注射到雞的胸肌内。對於其餘疫苗接種,係、將細菌製備物與不完全Freund,s氏佐劑混合後,以兩週間隔注射到 雞内長達6個月。 。從超免疫化雞收集卵後,噴霧乾燥成粉末形式。於喷霧乾 燥私序中’人口溫度不可超過32(Γρ,出口溫度係根據產生 的和在3 · 0 土 4 · 0 %成品溫度範圍而維持住,且栗壓係保持 在約M0 0至4000 P.s」M吏用1〇〇_16〇卞的輕低溫度且 在乾燥過程中監測樣品的溼度以得到具有所欲任何稠密性 之最後產物。 實例2 純化抗發炎組合物交佳方法 下面諸實施例說明從禽卵得到呈部份純的低分子量非聚集 形式&lt;抗發炎組合物所用方法(適用於大規模純化)。將全 卵二,免疫印和對照食印打破且將卵白與卵黃分開並將兩 者噴霧乾燥。超免疫卵係依實施例1中所述得到的。卵白粉 末經分開加工得到水性部份物供超濾所用。 所有純化步騾都在減少可能的細菌或熱原之污染下實施。 使用無菌水製備溶液且所有玻璃器具皆經脫熱原處理。此 外’溶液皆經無菌過濾過。 -34- 本紙張尺度適用CNS ) Α4規格(2敝297公^7 ---------------IT—^-----# (請先閲讀背面之注意事項再填寫本頁) 1221772 經濟部中央標準局員工消費合作衽印絮 A7 B7 五、發明説明(32 ) 實例2 a 從卵黃粉製備卵源抗發炎組合物 溶劑萃取 將依實施例1製得之乾燥卵黃用丙烷,或丁烷進行液體溶 劑萃取以從含抗發炎組合物的水性卵黃部份分離出脂質。 概言之,係將500克乾卵黃粉置於一管拄内,於其中加入4 升液體丙烷溶劑。取出溶劑上澄液及萃取出的脂質。進行 另外6次溶劑萃取以得總共6次脂質萃取。 超濾 將400克乾脫脂卵黃用4升無菌蒸館水稀釋並用virtis (handishear)予以勻化。將卵黃混合物以24 RPM離心或 使其靜止冷藏到未溶解卵黃粒子沈澱為止。所得水性部份 再用裝有3,000道耳呑截止率的螺旋繞組膜之Ami c〇n RA 1 000超濾系統予以超濾。泵速係維持在2〇 ?以入口壓力 及I5 psi出口壓力。使用〇.45微米無菌可丟置式Nalgene 遽器將&lt; 3,0 0 0道耳呑分子量濾透液無菌過濾、並予以冷;東乾 燥或冷凍貯存,生物檢定或進一步純化。圖1顯示出純化程 序之流程圖。 得自卵黃的低於3, 〇〇〇道耳呑分子物種含有呈低分子量非 聚集形式之抗發炎組合物。從4 0 0克起始物得到約1 2克或整 體的3 %之抗發炎組合物。對此3 KDa部份物針對抗發炎活 性進行生物檢定法檢驗顯示出高活性水平(實施例5 )。 實例2 b 毯卵白粉製備卵源抗發炎組合物 -35- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29?公釐) (請先閲讀背面之注意事項再填寫本頁) -1%. 訂 1221772Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Prepare the killed pathogen preparation as described above. For the first vaccination, the bacteria were mixed with complete Freund's adjuvant and 56 grams of bacterial material was injected into the chicken's pectoral muscles. For the rest of the vaccination, the bacterial preparation was mixed with incomplete Freund's adjuvant and injected into chickens at two-week intervals for up to 6 months. . After eggs are collected from hyperimmune chickens, they are spray-dried into powder form. In the spray drying private sequence, the population temperature must not exceed 32 (Γρ, the outlet temperature is maintained according to the generated sum in the range of 3 · 0 · 4 · 0% of the finished product temperature, and the chest pressure system is maintained at about M0 0 to 4000 The PS was monitored at a low temperature of 100-160 ° F and the humidity of the sample was monitored during the drying process to obtain the final product with any desired consistency. Example 2 Purification of anti-inflammatory compositions The example illustrates the method used to obtain a partially pure, low molecular weight, non-aggregated form of anti-inflammation composition from poultry eggs (suitable for large-scale purification). The whole egg two, the immune seal and the control food seal are broken, and the egg white is separated from the yolk The two were spray-dried. Hyperimmune eggs were obtained as described in Example 1. Egg white powder was separately processed to obtain aqueous fractions for ultrafiltration. All purification steps are reducing possible bacteria or pyrogens. Contaminated. The solution is prepared with sterile water and all glassware is depyrogenated. In addition, the solution is sterile-filtered. -34- This paper is sized for CNS) A4 size (2 公 297mm ^ 7 --- -------- ---- IT — ^ ----- # (Please read the notes on the back before filling in this page) 1221772 Employees' cooperation cooperation of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (32) Example 2 a Solvent extraction of egg-derived anti-inflammatory composition from egg yolk powder The dried egg yolk prepared according to Example 1 was subjected to liquid solvent extraction with propane or butane to separate lipids from the aqueous egg yolk portion containing the anti-inflammatory composition. In other words, 500 g of dried egg yolk powder was placed in a tube of tincture, and 4 liters of liquid propane solvent was added thereto. The solvent solution and the extracted lipids were taken out. Six additional solvent extractions were performed to obtain a total of six lipid extractions. Ultrafiltration dilutes 400 grams of dry defatted yolk with 4 liters of sterile steamed water and homogenizes with virtis (handishear). The yolk mixture is centrifuged at 24 RPM or left to stand until undissolved yolk particles precipitate. Ultrafiltration was performed using an Ami con RA 1 000 ultrafiltration system equipped with a spiral wound membrane with a cutoff rate of 3,000 channels. The pump speed was maintained at 20 ° with inlet pressure and I5 psi outlet pressure. 0.45 microns was used. Sterile Disposable Nalgene The sterilizer aseptically filters &lt; 3,000 molecular weight permeate, and freezes it to dry or freeze it for storage, bioassay or further purification. Figure 1 shows the flow chart of the purification procedure. The molecular species of less than 3,000 canals have anti-inflammatory compositions in a low molecular weight non-aggregated form. Approximately 12 grams or 3% of the entire anti-inflammatory composition is obtained from 400 grams of starting material. This 3 KDa portion was tested for anti-inflammatory activity by bioassay and showed a high level of activity (Example 5). Example 2 b Preparation of egg-derived anti-inflammatory composition from blanket egg white powder -35- This paper size applies Chinese national standards ( CNS) A4 size (210X29? Mm) (Please read the notes on the back before filling out this page) -1%. Order 1221772

經濟部中央標隼局員工消費合作社印製 將自實施m所述超免疫卵和對照食用卵分離出的彻克 印白用4升去離子水予以稀釋。將混合物勾化並濾經-40微 米遽器且超滤過一 3 KDa M w c〇超遽系統(圖2)。從例 克卵白粉,回收到8.6克或2.15%的抗發炎組合物。 此實施例顯示從超免疫卵與對照食用卵兩者的卵白物質製 備活性抗發炎組合物。 實例3 E離子交換層折術 卵源抗發炎組合物以陰離子交換DEAE層析術進一步分 析。Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. The Choke White isolated from the hyperimmune eggs and control edible eggs described in m was diluted with 4 liters of deionized water. The mixture was decanted and filtered through a -40 micron scaler and ultra-filtered through a 3 KDa Mwco ultrafiltration system (Figure 2). From the grams of egg white powder, 8.6 grams or 2.15% of the anti-inflammatory composition was recovered. This example shows the preparation of an active anti-inflammatory composition from egg white matter of both hyperimmune eggs and control edible eggs. Example 3 E ion exchange layer folding The egg-derived anti-inflammatory composition was further analyzed by anion exchange DEAE chromatography.

以實例2中所述相同方式從經脫脂卵黃和卵白兩者製備 J,000道耳呑超滤穿透液。將DEAE Sepharose管柱 (2.5x40.0公分)事先在室溫下用1 000毫升2〇 mM,pHIn the same manner as described in Example 2, J, 000-channel ear canal ultrafiltration penetrating fluid was prepared from both defatted yolk and egg white. A DEAE Sepharose column (2.5x40.0 cm) was pre-treated at room temperature with 1 000 ml of 20 mM, pH

8.0 ’在無菌雙重蒸館無熱原水中的乙酸按緩衝液予以平衡 過。將脫脂卵黃(1 5克)或即白(1 8克)的3,0 0 0道耳呑穿透液 溶在200毫升無菌無熱原雙重蒸餾水内並以丨00毫升/時的 流速施加到DEAE Sepharose管柱上(Pharmacia Biotech.,Fast flow)。用下述諸緩衝液洗提3,000道耳呑 穿透液所含諸成分以分離出卵源抗發炎組合物和它分子。 在相同流速下,係使用2 0 0毫升2 0 m Μ p Η 8.0乙酸銨和 200毫升2〇 mM pH 6.5乙酸銨洗提DEAE Sepharose以脫 除未結合物質。然後施加2 〇 0毫升1 5 0 m Μ p Η 5.0乙酸按 以洗提弱結合分子。較強結合分子係用2 0 0毫升1 5 0 m Μ pH 4.0乙酸銨洗提出。最後用400毫升1.5Ν NaCl/20 mM 36 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) (請先閲讀背面之注意事項再填寫本頁) 訂 1221772 A7 B7 五、發明説明(34 乙酸銨,pH 6.5再生DEAE Sepharose管柱(圖3)。 圖3顯不出用DEAE Sepharose分離從脫脂卵黃和卵白所 得3 Kda穿透液之典型層析譜。字母指示出用諸緩衝液所得 洗提型態。以每1 5毫升洗提液收集諸部份液並測量共在2 8 〇 nm和220 nm的分子吸光度。合併4洗提液份並冷凍乾燥脫 除水分。表2概列出分離結果。 表2 脫脂卵黃和卵白的3,000道耳呑穿透液之DEAE分離 癌積(毫升) 部份物 洗提井 重量(克) 回收率 請 先 閲 讀 背 面 5 ί 事 項 再 填 寫 本 頁 1-22 23-40 41-56 57-70 2-26 27-46 47-60 61-73 294 252 224 196 350 280 196 182 11.79 0.40 0.44 0.19 15.33 0.23 0.32 0.44 78.6 2.7 2.9 1.3 85.2 1.3 1.8 2.4 實例4 3,000道耳 呑穿透8.0 'Acetic acid in pyrogen-free water in a sterile double-distillation chamber was equilibrated with buffer. Dissolve defatted egg yolk (15 g) or white (18 g) 3,0 ear canal penetrating solution in 200 ml of sterile pyrogen-free double distilled water and apply it at a flow rate of 00 ml / hour DEAE Sepharose column (Pharmacia Biotech., Fast flow). The components contained in the 3,000 ear piercing solution were eluted with the following buffers to separate the egg-derived anti-inflammatory composition and its molecules. At the same flow rate, DEAE Sepharose was eluted with 200 ml of 20 μM pΗ 8.0 ammonium acetate and 200 ml of 20 mM ammonium acetate pH 6.5 to remove unbound material. Then, 500 ml of 150 m M p Η 5.0 acetic acid was applied to elute the weakly bound molecules. The stronger binding molecule was washed with 200 ml of 150 m mM ammonium acetate pH 4.0. Finally, use 400ml 1.5N NaCl / 20 mM 36. The paper size is applicable to Chinese National Standard (CNS) A4 (210 X 297 mm) (Please read the precautions on the back before filling this page) Order 1221772 A7 B7 V. Invention Description (34 Ammonium acetate, pH 6.5 regeneration of DEAE Sepharose column (Figure 3). Figure 3 does not show a typical chromatogram of 3 Kda penetrating fluid obtained from defatted yolk and egg white using DEAE Sepharose. Letters indicate the use of buffers The obtained elution pattern of the liquid was collected. Each part of the 15 ml of the eluate was collected and the molecular absorbances at a total of 2800 nm and 220 nm were measured. The 4 eluate fractions were combined and lyophilized to remove water. Table 2 The separation results are summarized. Table 2 DEAE Separation Carcinoma Volume (ml) of 3,000 Ear Penetrating Fluids of Defatted Yolk and Egg White Weight of Extraction Well (g) Recovery Rate Please read the back 5 first and fill in this Page 1-22 23-40 41-56 57-70 2-26 27-46 47-60 61-73 294 252 224 196 350 280 196 182 11.79 0.40 0.44 0.19 15.33 0.23 0.32 0.44 78.6 2.7 2.9 1.3 85.2 1.3 1.8 2.4 Examples 4 3,000 Ear Ear Penetrations

液及其DEAELiquid and its DEAE

Sepharose 洗接液份之 經濟部中央標準局員工消費合作社印裝 Η P L C分析 用逆相南性能液體層析術(Η P L C) (S h i m a d z u U n i t, SPD-M 10A VP Diode array 偵檢器,LC-6AD 液體層析 儀’ SCL-10A VP除氣器,LPM-600低壓混合,及CTO-10A VP管柱烘箱)分析卵黃的3,〇〇〇道耳呑穿透液。所有洗 提液分都製備成5.0毫克/毫升超純水接著濾經〇 . 2微米濾 器。如20械升各樣品施加在29 C的Waters Symmetry -37- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 1221772 A7 B7 表 經濟部中央標隼局員工消費合作社印掣 五、發明説明(35 C18管柱(3.9x150^米)上’流速為1〇毫升/分。使用〇% -60%乙腈/d H20/〇.1%TFA的線型梯度作為移動相。 圖4顯示出脫脂PL-100卵黃所得3,〇〇〇道耳呑穿透液經分 離產生之Max標繪層析譜。使用相同的分析條件,也對從 脫脂食用卵卵黃製得的3,0 〇 〇道耳呑穿透液得到層析结果 (層析譜未示出)。 表3摘列出3,000道耳呑穿透液的HPLC分析結果。將大 於〇 · 5 % 1晋峯面積的譜秦液分收集起來。於其滯留時間+/ _ 0.5變異性之内比較諸譜皋的類似性。共同譜峯意指彼等同 時存在於PL-100卵黃和食用卵卵黃之中而?1]〇〇譜条指其 僅存在於P L - 1 0 0卵中。比較兩部份物之下,p [ ·丨〇 〇卵黃的 3,0 0 0道耳呑穿透液顯示出比食用卵卵黃所具者多出丨5譜 条,可推測雞的超免疫化能夠在其卵内產生更多的生物成 分。 jKD穿透液共同譜峯PL_100譜襄石用卵譜秦~ PL-100 卵 18 15 —&quot;〇 ^ 食用卵 18 〇 5 23Sepharose Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. 逆 PLC analysis liquid chromatography (Η PLC) (S himadzu Unit, SPD-M 10A VP Diode array detector, LC -6AD Liquid Chromatograph's SCL-10A VP Degasser, LPM-600 Low-pressure Mixer, and CTO-10A VP Column Oven) Analyze 3, 000 ear piercing fluids from yolk. All eluent fractions were prepared as 5.0 mg / ml ultrapure water and then filtered through a 0.2 micron filter. For example, 20 mechanical liters of each sample is applied at 29 C Waters Symmetry -37- This paper size is applicable to China National Standard (CNS) A4 specifications (210X 297 mm) 1221772 A7 B7 2. Description of the invention (35 C18 column (3.9x150 ^ m). The flow rate is 10 ml / min. A linear gradient of 0% -60% acetonitrile / d H20 / 0.1% TFA is used as the mobile phase. Figure 4 shows Max plotting chromatogram of Max produced by defatted PL-100 egg yolk with 3,000 channels. The same analysis conditions were also used for 3,000,000 obtained from defatted edible egg yolk. The chromatographic results were obtained from the Dalbergia penetrating solution (chromatograms are not shown). Table 3 summarizes the HPLC analysis results of 3,000 Dalbergia penetrating solutions. The Qin solution with a peak area greater than 0.5% 1 The fractions were collected. The similarity of the spectrum maggots was compared within their retention time +/- 0.5 variability. The common spectrum peak means that they exist in both PL-100 yolk and edible egg yolk? 1] 〇〇 The band indicates that it is only present in PL-100 eggs. Comparing the two parts, p [· 丨 〇〇3,0 0 0 The ear penetrating fluid showed 5 more bands than those of yolk yolk, and it can be speculated that the chicken's hyperimmunization can produce more biological components in its eggs. JKD penetrating fluid common spectrum peak PL_100 spectrum Xiang Stone egg spectrum Qin ~ PL-100 Egg 18 15 — &quot; 〇 ^ Edible egg 18 〇5 23

製備型H D L C 為了在超濾後得到大量的抗發炎因小,較佳的步驟是在一 製備型Η P L C管柱上分離經部份純化,低於約3,〇 〇 〇道耳呑 分子量的組合物。因此,用Ζ 〇 rb ax C 8填充材料填充一 :&gt;.0 8 X 2 0公分管柱並於每一流中純化*克低於3,〇 〇 〇道耳吞 MW的超滤物。使用80/20 H2〇/甲醇加〇〇5%TFA作為移 -38- 本紙悵尺度適用中國國家標準(CNS ) M規格(2丨〇&gt;&lt; 297公釐) --------4! (請先閲讀背面之注意事項再填寫本頁} 詐 經濟部中央標準局員工消費合作社印製 發明説明(36 ) ,相’流為9G毫牛/分’將穿透液分離成部份純化組合物, 了以收集與冷凍乾燥。 木接者,將收集到的譜峯再於分析型 g王议β。以所述方法,經由製備型HPI^C及分析並 士物檢定活性,元素組成和化學構造,得到大量超純譜 7用質譜分析術,元素分析,紅外光光譜分析術和核 磁共振(NMR)測定因子的構造。 實例5 上卵產兔節炎模型中之抗關節炎性 -質 &quot;_&quot; 老^體内膠原謗發關節炎是風濕關節炎的一種普遍性實驗 動物模型且在1 977年後即為數個實際室和研究機構所用。 自其初始發現之後,膠原誘發關炎動物模型即經證實與人 類風關節炎有許多相似處。例如,和同事們即證明 在關印炎老鼠的關節中有數個臨床跡象和病歷變化類似於 人類風濕關節炎患者(stuan et al,1 9 8 3 ),特別重要者 為許多風濕關節炎患者展現出對第„型膠原的自體免疫性之 事實。、在過去,這種動物模型已證明為新的具有抑制性質 &lt;形式及就抗關節炎作用而言的潛在免疫調節性物質所具 臨床效益之有用預測模型。小鼠和老鼠體内的關節炎通常 係用異源性第Π型膠原予以免疫化而誘發的,其係針對關節 組織起始合併的體液與細胞免疫反應。現有的療法皆不勝 任或具有副作用而限制彼等的長期用途。 本實施例著眼於本發明卵產物和部份純化抗發炎組合物於 用膠原II進行關節炎謗發之前與之後給老鼠經口服用^具效 (請先閱讀背面之注意事項再填寫本頁) T 、! -39- 122177?Preparative HDLC In order to obtain a large amount of anti-inflammatory agents after ultrafiltration, the preferred step is to separate and purify a combination of molecular weights below about 3,000 channels on a preparative PLC column. Thing. Therefore, one was filled with Z rb ax C 8 packing material: &gt;. 0 8 X 2 0 cm tube column and purified in each stream * g ultrafiltration of less than 3,000 channel MW. Use 80/20 H2O / methanol plus 5% 5% TFA as the shift-38- This paper's standard is applicable to the Chinese National Standard (CNS) M specification (2 丨 〇 &lt; 297 mm) ------- -4! (Please read the notes on the back before filling out this page} Printed invention description (36) printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Fraud Economics, the phase is 9G milliN / min. The purified composition was collected and lyophilized. The person who collected the samples then re-collected the peaks in the analytical g Wang Yi β. In the method described above, the activity was determined by preparative HPI ^ C and analysis and analysis. Elemental composition and chemical structure, a large number of ultrapure spectra were obtained. 7 Mass spectrometry, elemental analysis, infrared spectroscopy, and nuclear magnetic resonance (NMR) were used to determine the structure of the factors. Sex-Quality &quot; _ &quot; Lao ^ In vivo collagen and arthritis is a universal experimental animal model of rheumatoid arthritis and has been used by several practical laboratories and research institutions since 1977. Since its initial discovery, collagen Animal model of induced inflammation has been shown to be related to human rheumatoid arthritis Similarities, for example, and colleagues have shown that there are several clinical signs and changes in medical records in the joints of Guanyinyan mice similar to those of human rheumatoid arthritis (stuan et al, 198 3), especially important for many rheumatoid joints The fact that patients with inflammation show autoimmune to collagen type. In the past, this animal model has proven to be a new inhibitory form &lt; form and a potential immunomodulatory substance in terms of anti-arthritis effect A useful predictive model for clinical benefit. Arthritis in mice and mice is usually induced by the immunization with heterologous type II collagen, which is a response to the initial combined humoral and cellular immune responses of joint tissues. Existing therapies are incompetent or have side effects that limit their long-term use. This example focuses on the egg product and partially purified anti-inflammatory composition of the invention before orally administered to mice before and after arthritic slurries with collagen II. Effective with ^ (Please read the precautions on the back before filling this page) T ,! -39- 122177?

應。關節炎發生的受壓抑係相對於對照組以劑量 進行探討。 入 方法 將重 100 125 克的 30 隻 Sprague-Dawiey 潍鼠+ (Charles RiVers,Wllmingt〇n,μα)隨機分配成 3 組(動 物/組)貝颟係經重複三次使得最後組別包括3 〇老鼠/處理 法而使本研究總共有9〇隻老鼠。將嘴霧乾燥超免疫卵產物 (依實施例1製得者)稀釋供經口強飼用。每隔—天製備供經 口強詞用的10%和〇.2%卵產物溶液。第二天係將溶液貯存 在4 C到要用為止。在起始老鼠的第π型膠原謗發關節炎前 的七天及謗發後的丨4天將卵產物(3 · 5毫升各溶液)經口強飼 給老鼠。 在老鼠體内誘發和評估關節炎的方法係根據T r e nth am e t al· 1 977而行的。概述之,係將Spragu卜Dawley老鼠於下 背邵經由皮内接種400烴胃蛋白酶處理的自然第][1型小雞膠 原(CII)( Genzyme,Boston,MA)而免疫化,該膠原(cn) 經濟部中央標準局員工消費合作社印裝 (請先閱讀背面之注意事項再填寫本頁) 係落在0. 1M乙酸中成1毫克/毫升且經不完全以⑼以、氏經 劑1 : 1乳化者。三個組:水強飼組(對照組),5 〇 χ超免疫蛋 產物組(南劑量組)(3 . 5毫升1 〇 %超免疫卵產物溶液)與1 χ 超免疫卵產物組(低劑量組)(3.5毫升〇 . 2 %超免疫卵產物溶 液)’母組1 0雙老鼠。在皮下膠原11免疫化後的第1 〇天開始 及其後的每天到第2 1天為止,臨床評估老鼠(盲式)每一肢 的鼠爪關節周圍紅斑(0-4 + )與鼠爪腫脹(〇-4 + )。 組關節炎指數(ΑΙ)為根據關節炎發生程度為基的爪評分與 -40- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) -- 經濟部中央標準局員工消費合作社印裝 1221772 五、發明説明(38 ) I均Am生的關節炎嚴重性之和。於第21天,將所 救叱和放血。對血清評估針對第_膠原抗體力價。使ς 素聯結免疫檢定(ELISAis)測量針對第π型膠原㈣争奸 體力價(Trentham et al. 1 983)。然後以超劑量: metafane殺死動物。 結果 DCV卵產物在第„型膠原老鼠模型中劑量相關方式顧于 出明確的抗關節炎性質。 ” 高劑量DCV卵產物食用在此模型中經由影響免疫系統的 細胞和體液分部而清楚地展現出抗發炎性質。 孩化合物在低和高兩劑量下顯現為無毒性者。高劑量組相 對於水對照組不僅在關節炎發生上顯示出具統計意義的減 低,而且也延緩關節炎的超始及減低關節炎嚴重度。 圖5顯示出在用第„型膠原進行免疫化之前服用高劑量卵 產物可以沒有服用卵者防止更多的動物發展出關節炎徵 候。=外,在用印產物處理的11天内及其後在本研究的整 個持績期中,可以觀察到相對於沒有接受任何卵的組合言 明顯減低的關節炎發生率。 用S-100和PL-100全卵可在第1](型膠原謗發關節炎模型 中觀祭到柷關節炎效應,將卵分離後,卵黃在動物模型中 顯示出抗關節炎活性但卵白則否。不過,將相同的卵黃脫 月曰即元全消除掉抗關節炎活性。此種脫脂卵黃經3,〇 〇 〇分子 f截止尺寸排除管柱進一步純化,且於老鼠第丨丨型膠原模型 中檢驗。孩邯份純邵份物顯示出與全P L _丨〇 〇卵所示者相稱 -41 - 本紙張尺度適用中國國家標準(CNS ) A4規格(2i〇X297公釐) 1«·_ »,1.1 _:丨 i ·「! (請先閲讀背面之注意事項再填寫本頁) ....... fyi - ...... ί 、-口 擎 ί 1-ί Γϋ 1221772 A7 B7 五、發明説明( 39 之南抗關節炎活性。 另一項完成的重要觀察為用PLd 00卵飼餵的老鼠在其血 清中所含針對第II型膠原的抗體比對組動物有統計意義地減 低。此點顯示PL-100卵在該等動物體内具有免疫壓抑放應 且由是有助於減緩彼等動物關節中的關節炎徵候。 表4 爷高關節炎發生率的平均日數 實驗 實驗2 對照組 14 高劑量 (請先閲讀背面之注意事項再填寫本頁) d 經濟部中央標準局員工消費合作杜印製 ------ A ^ ____1^. *在用膠原II免疫化之後最高關㊣炎發生的始有延緩 在第2丨天時,於接受高劑量超免疫即產物的動物體内反 映出關節炎程度與嚴重度之關節炎指數相對於對昭组有明 顯地減少(2.46±0.55 相對於 4 167 土 〇 51 ; p-o 〇〇3, S^dent t式驗)。低劑量卵產物的效應則與對照組沒有明顯 爰異。此外,纟高劑量組内的關節炎發生率相對於對昭纽 有明顯地壓抑(30%相對於7G% W3)。高劑量超免 ㈣屋物所看到的這種關節炎百分發生率之減少如同對類 固S子NSAIDS(非一類固醇抗發炎藥物)氨甲蝶吟,和二 胺四環素所報導過者一樣好。 :广實施例也顯示在誘發關節炎之前給用高劑量卵產物可比 沒有接受卵者防止更多的重铷 展現於圖6之中。觸發展出關…這些結困指 訂 42- 1221772 、 五 皆明説明( 40 圖6顯示出高劑量_產物對關節炎的預防。經口強飼卵启 的動物相對於沒有接受卵的對照組動物有較低百分比潑 :出_徵候。動產係經口強飼2 i天,免疫化(關節炎詞 發)之前的七天及免疫化後14天。 結論 口 顯示出卵產物在第Π型膠原謗發老鼠關節炎模型中有 、主U里相關万式的明確抗關節炎效應。於接受高劑量超免 ^ _產物的動物中觀察到其關節炎發生率有具統計意義地 減低,起始有延緩且其嚴重度有減低。此數據顯示高劑量 Μ,對關節炎發生有㈣效果。最重要者,於高和低兩 種劑I的情沉下,超免疫卵產物皆無毒性。 實例6 歷原11抗體的減少 將肓例5的老以於第2 1天放血並收集血清樣品。使用標準 ELIS Α檢定測是抗膠原〗!自體免疫性抗體的力價。這些結 果,證明食用高劑量或低劑量蛋產物的動物相對於對照組 可將膠原11抗體力價明顯地降低(表5)。 ---------#|丨 (請先閱讀背面之注意事項存填寫本頁)should. The suppression of arthritis was investigated in doses relative to the control group. 30 Sprague-Dawiey rats (Charles RiVers, Wllmington, μα) weighing 100 125 g were randomly assigned into 3 groups (animals / groups). The shellfish line was repeated three times so that the final group included 3 mice. / Treatment resulted in a total of 90 mice in this study. Mouth mist-dried hyperimmune egg products (made according to Example 1) were diluted for oral gavage. Every 10 days, 10% and 0.2% egg product solutions were prepared for oral use. The next day, the solution was stored at 4 C until needed. The egg product (3.5 ml of each solution) was orally fed to the mice seven days before the start of type π collagen and arthritis in the mice and 4 days after the inflammation. The method for inducing and assessing arthritis in mice is based on T r enth am e t al · 1 977. In summary, Spragu and Dawley mice were immunized by intradermal inoculation with 400 hydrocarbon pepsin-treated natural skin] [type 1 chicken collagen (CII) (Genzyme, Boston, MA) and the collagen (cn ) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page). It falls in 0.1 M acetic acid to 1 mg / ml and is not completely treated with the following formula: 1 emulsifier. Three groups: water feeding group (control group), 50 × hyperimmune egg product group (south dose group) (3.5 ml of 10% hyperimmune egg product solution) and 1 × hyperimmune egg product group (low Dose group) (3.5 ml 0.2% hyperimmune egg product solution) 'mother group 10 pairs of mice. The erythema (0-4 +) and rat paw around the paw joints of each limb of the mouse (blind) were clinically evaluated starting on the 10th day after the subcutaneous collagen 11 was immunized and daily until the 21st day. Swelling (0-4 +). The group arthritis index (ΑΙ) is based on the claw score based on the occurrence of arthritis and -40- This paper size applies the Chinese National Standard (CNS) Α4 specification (210 × 297 mm)-printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs装 1221772 V. Description of the invention (38) I is the sum of the severity of arthritis of Am. On day 21, rescued and bleeded. Serum was evaluated against the collagen antibody titer. The ELISA-linked immunoassay (ELISAis) measures physical price against type π collagen ㈣ (Trentham et al. 1 983). Animals were then killed in an overdose: metafane. Results The anti-arthritis properties of DCV egg products were considered in a dose-dependent manner in the collagen type Ⅰ mouse model. "High-dose DCV egg product consumption is clearly demonstrated in this model via the cell and humoral segments that affect the immune system. Provides anti-inflammatory properties. Child compounds appear to be non-toxic at both low and high doses. Compared with the water control group, the high-dose group not only showed a statistically significant reduction in the occurrence of arthritis, but also delayed the onset of arthritis and reduced the severity of arthritis. Figure 5 shows that taking high-dose egg products before immunization with type I collagen can prevent more animals from developing arthritis symptoms without eggs. = In addition, within 11 days of treatment with printed products and later in this Throughout the study period, a significant reduction in the incidence of arthritis relative to the combination that did not receive any eggs was observed. S-100 and PL-100 whole eggs can be used in the first 1] (type collagen deflated arthritis model) Meso-sacrifice shows the effect of sacroiliitis. After the eggs are separated, the yolk shows anti-arthritis activity in the animal model but not the egg white. However, the same yolk is removed and the anti-arthritis activity is eliminated. This This defatted yolk was further purified by a 3,000-molecule cut-off size exclusion column and tested in a rat collagen type 丨 丨 model. The pure fractions of children's liver showed the same results as those shown in the full PL _ 丨 〇〇 eggs.者 相 相 -41-This paper size applies to China National Standard (CNS) A4 (2i × 297mm) 1 «· _», 1.1 _: 丨 i · "! (Please read the notes on the back before filling this page ) ....... fyi-... ί, -mouth ί 1-ί Γϋ 1221772 A7 B7 V. Explanation of the invention (39 South Anti-arthritis activity. Another important observation completed is that mice fed with PLd 00 eggs have antibodies against type II collagen in their serum. The animals in the comparison group were statistically reduced. This point shows that PL-100 eggs have an immunosuppressive response in these animals and therefore help to slow down the arthritis symptoms in their joints. Table 4 Yegao joints The average number of days of the experimental rate of inflammation. Experiment 2 Control group 14 High dose (please read the precautions on the back before filling this page) d Printed by the consumer cooperation of the Central Standards Bureau of the Ministry of Economic Affairs ------ A ^ ____ 1 ^ * The delay in the occurrence of maximal inflammation after immunization with collagen II was delayed on day 2. In animals receiving high-dose hyperimmune products, the arthritis index was reflected relative to the severity of arthritis index. There was a significant reduction in the Zhao group (2.46 ± 0.55 vs. 4 167 soil 〇51; po 〇03, S ^ dent t test). The effect of low-dose egg products was not significantly different from the control group. In addition,相 The incidence of arthritis in the high-dose group It has a significant depression on Zhao New (30% vs. 7G% W3). The reduction in the percentage of arthritis seen with high-dose ultra-free squatters is similar to that of steroid NSAIDS (non-steroids) Anti-inflammatory drugs) methotrexate, as good as those reported by diamine tetracycline.: The examples also show that giving a high dose of egg product before inducing arthritis can prevent more weight loss than those without egg recipients. In Figure 6. Triggered off ... These knotty fingers 42-1221772, Wu Jieming instructions (40 Figure 6 shows the high-dose product to prevent arthritis. Oral gavage animals had a lower percentage of syphilis than control animals that did not receive eggs. Movables were given by oral gavage for 2 i days, seven days before immunization (arthritis) and 14 days after immunization. CONCLUSION: It is shown that egg products have a clear anti-arthritis effect in the type II collagen-induced mouse arthritis model. A statistically significant decrease in the incidence of arthritis was observed in animals receiving high-dose superimmuno ^^ products, with a delayed onset and reduced severity. This data shows that high doses of M have a stinging effect on arthritis. Most importantly, the hyperimmune egg products were non-toxic in the presence of both high and low doses of I. Example 6: Reduction of Libo11 antibody The old man of Example 5 was bled on day 21 and a serum sample was collected. Anti-collagen test using standard ELIS Α test! The potency of autoimmune antibodies. These results demonstrate that animals consuming high- or low-dose egg products can significantly reduce the collagen 11 antibody titer relative to the control group (Table 5). --------- # | 丨 (Please read the notes on the back and save this page)

T 經濟部中央標準局員工消費合作社印製 對照組 低劑量組 高劑量組 膠原II抗體 力價(-log2) 9·3±〇·〇3 8.5 ±0.28 8.3 ±0.36 統計意義 — Ρ &lt; 0.004 _ Ρ &lt; 0.005 在用卵產物強飼的動物血清中所含對膠原Z Z的自體免疫 性抗體力價比對照組動物(沒有食用卵產物)所含者較為 -43 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 1221772 A7 B7 五、發明説明(41 經濟部中央標準局員工消費合作社印製 減少之事實具有高度意義。因為所有組的動物都接受相同 水平的膠原II來謗發對膠原„的抗體及所導致之關節炎徵 侯所以接文卵產物的組却在第2丨天具有較低的膠原11抗 體為價之事實係意料之外者。這種膠原π抗體力價的減少 顯示超免疫卵產物對於細胞和體液兩種免疫反應都是正面 的影響。 實例7 本實施例顯示出超免疫卵(依實例丨製得者)對於在食用 包含超免疫卵的食物之狗體内經角叉藥膠謗發皮膚水腫之 抗發炎作用。彼等結果證實超免疫卵可減低發炎。其對發 炎的影響可比擬用非一類固醇抗發炎藥物異丁苯丙酸 Gbuprofen)在此試驗中以1〇毫克/公斤,ed〜,劑量所 付之結果。 對2〇隻Whlte Eagle Beagles (四組各含5隻狗)餵以 Ψ售黑羊肉及狗米食基本食物(35G克)。如表2中所示 者兩、復各5隻狗(第i和第2兩組)於約1〇〇天的調理期 間只^雙基本食物。此外,第2組的狗在用角叉藥膠發炎刺 激之前’另外用非類固醇抗發炎藥,異丁苯丙酸,予以處 理。於此相同期間,其餘兩組(3&amp;4 )則用基本食物加上 超免疫卵(HIE)飼銀。第3組接受加到食物中的以克 超免疫_ *第4組接τ 3)克加到食物中的超免疫印。於 調理食物處理結束時,經由皮下注射2%角叉藥膠刺激諸狗 並诱發出發炎反應。 該刺激程序如下所述。每一天從每一组隨機地選出—隻狗 (請先閱讀背面之注意事項再填寫本頁) 1r • — - - ill I -I m — I i· -44- 〜1/72T Printed by the Consumers' Cooperative of the Central Standard Bureau of the Ministry of Economic Affairs of the control group Low-dose group High-dose group Collagen II antibody potency (-log2) 9 · 3 ± 〇 · 〇3 8.5 ± 0.28 8.3 ± 0.36 Statistical significance — P &lt; 0.004 _ Ρ &lt; 0.005 The potency of autoimmune antibodies against collagen ZZ contained in the serum of animals fed with egg products is higher than that in control animals (without edible egg products) -43 This paper applies Chinese national standards (CNS) A4 specification (210X 297 mm) 1221772 A7 B7 V. Invention description (41 The fact that the printing of employees' cooperatives in the Central Standards Bureau of the Ministry of Economic Affairs has been reduced is of great significance. Because all groups of animals receive the same level of collagen II. The fact that the antibodies against collagen and the resulting arthritis symptoms led to the receipt of egg products on the second day has a lower collagen 11 antibody value is unexpected. This collagen π antibody The reduction of the force value indicates that the hyperimmune egg product has a positive effect on both the cellular and humoral immune responses. Example 7 This example shows that the hyperimmune egg (made according to the example 丨) has a significant effect on food consumption. The anti-inflammatory effect of hyper-immune eggs in dogs with carrageenan on skin edema is confirmed by their results. Their results confirm that hyper-immune eggs can reduce inflammation. Their effects on inflammation can be compared with non-steroid anti-inflammatory drugs. Gbuprofen) was used in this test at a dose of 10 mg / kg, ed ~, and 20 Whlte Eagle Beagles (four groups of 5 dogs each) were fed with black lamb and dogs Rice basic food (35G grams). As shown in Table 2, two dogs (groups i and 2) each had only two basic foods during the conditioning period of about 100 days. In addition, the 2nd The dogs in the group were treated with a nonsteroidal anti-inflammatory drug, ibuprofen, before being stimulated with carrageenan. In the same period, the remaining two groups (3 &amp; 4) were treated with basic food plus super Immunized eggs (HIE) were fed with silver. Group 3 received hyperimmunization with gram added to the food. * Group 4 received τ 3) grams of hyperimmunized mark added to the food. At the end of the conditioning food treatment, it was injected subcutaneously. 2% carrageenan stimulates dogs and induces an inflammatory response. The stimulation procedure is described below. Every day randomly selected from each group—dogs (please read the notes on the back before filling this page) 1r • —--ill I -I m — I i · -44- ~ 1/72

A7 B7 發明説明(42) — 進订刺激和檢驗。此程序每日重複進行共天直到所有組内 勺所有狗都經檢驗為止。於刺激程序前的1 5分鐘,對第2 、'、且的狗經口餵以1 〇毫克/公斤的異丁苯丙酸。所有狗都經由 靜脈内注射予以麻醉並將其左側面的毛剃掉(約6 X 8 才)。於剃過的部位上加上兩行各3個記號且予以編號! _ 於兄號1施以皮内注射0.1毫升食鹽水作為陰性對照。 :於u己號2 - 6,則施以皮内注射〇 · 1晕升的2 %角叉藥膠溶 硬。於本研究的持續期内皆由相同的人實施注射。此濃度 的角又藥膠之皮内注射係經事先測定可在i 〇 〇 %動物體内造 成可測量的腫脹,彼等腫脹可用10毫克/公斤的異丁苯丙酸 了以減低。於取後一次角叉藥膠注射完畢時,使用測徵計 測量每一腫脹並記錄其數值。讓經麻醉的動物恢復且於6小 時後重複測量和記錄。對每一組測定發炎反應的平均大 --ϊ im «—.—1 i tm —nil ϋϋ· ml m mu ϋϋ ml ml 一 N (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 表6A7 B7 Invention Note (42)-Order Stimulation and Inspection. This procedure was repeated daily for a total of days until all dogs in all groups were tested. 15 minutes before the stimulation procedure, the 2nd, 2nd, and 3rd dogs were orally given 10 mg / kg of ibuprofen. All dogs were anesthetized by intravenous injection and the hair on their left side was shaved (approximately 6 X 8). Add 3 lines and 3 marks to the shaved area and number them! _ Yu Xiong No. 1 was intradermally injected with 0.1 ml of saline as a negative control. : In Uji No. 2-6, intradermal injection of 0.1% halo of 2% carrageenan gel was hardened. The injection was performed by the same person throughout the duration of the study. Intradermal injection of carrageenan at this concentration resulted in measurable swelling in the animal body of 1000%, and their swelling can be reduced with 10 mg / kg of ibuprofen. After the injection of carrageenan was completed, each swelling was measured using a levometer and the value was recorded. Allow the anesthetized animal to recover and repeat the measurement and recording after 6 hours. The average size of the inflammatory response measured for each group--ϊ im «—.— 1 i tm —nil ϋϋ · ml m mu ϋϋ ml ml 1N (Please read the precautions on the back before filling this page) Central Standards of the Ministry of Economic Affairs Bureau Cooperative Consumer Co-operative Prints Sheet 6

這些結果顯示出用超免疫卵銀養 克加基本食物 -45- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 1221772 A7 經濟部中央標準局員工消費合作社印製 五、發明説明(43 克加基本食物)的動物在腫脹上有明顯的減少,顯示超 :仄卵在經口飼餵時對於發炎有預防性效用。再者這些结 :顯:超免疫印所具抗發炎活性可與用抗發炎藥物,異丁 本丙§又’所看5彳的效用相當。在處理組與對照組之間可看 到P &lt; 0.0 5意義水平下的差異。 實例8 炎人類東去的影乡年 製得營養飲料補品其包括高蛋百質,高醣類粉末其中本有 3〇二,經議的每日容許量之維生素,及約4 5克的超免疫㈣ 17 (約寺於〇.4個卵)。該飲料補品係由DCV,Inc,These results show that the use of hyperimmune egg silver nougat and basic foods-45- This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297 mm) 1221772 A7 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs It shows that (43 grams plus basic food) animals have a significant reduction in swelling, showing that the super: pupa eggs have a preventive effect on inflammation when fed orally. Furthermore, these results show that the anti-inflammatory activity of hyperimmune imprinting can be comparable to that of anti-inflammatory drugs, isobutyl benzoate, and 5 ′. A difference at the significance level of P &lt; 0.0 5 can be seen between the treatment group and the control group. Example 8 A nutritional drink supplement made by Ying Xiangnian, a man who has gone east, includes high-protein, high-sugar powder, which has 302, a recommended daily allowable amount of vitamins, and about 45 grams of super Immune to 17 (about 0.4 eggs). The beverage supplement is made of DCV, Inc,

Wilmington,所提供。 , 、有三個患者服用該營養飲補品—段兩個月之期間。有關對 ^物耐t性之評估’係在研究之前經由每一患者對臨床狀 態的估測及詳細的臨床檢驗進行評估一個月,二個月及一 個月(停用產物後一個月)。此外也實施臨床化學,血$ 學和尿液分析監測。下文所述為每一患者的處理結果: 患者#1 ° * 患者#1為一 29歲婦女,5, 3,,17〇磅有風濕性關節炎 (幼稚型)之病歷。於第一次檢查時該患者呈現出手指, 腕,腳趾,腳,和膝之關節痛,腫脹,和柔軟。她抱怨有 啟能限制例如不能彎膝或跑步,且難以蹲下。其血液學柃 驗具有正常的紅血球沈著率(ESR )和。反應性蛋 (CRP )讀值。患者的胆固醇為】99亳克/公合。其瘦用 謝in 3 00毫克i週’ LoeminFe Mm治療過了且 -46 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公餐) MW—— (請先閱讀背面之注意事項再填寫本頁) 1Γ 1221772 A7Wilmington, provided. There are three patients taking this nutritional supplement—a period of two months. The evaluation of the material's t resistance was evaluated by each patient's assessment of clinical status and detailed clinical tests before the study for one month, two months, and one month (one month after the product was discontinued). In addition, clinical chemistry, hematology and urinalysis monitoring are also implemented. The treatment results for each patient are described below: Patient # 1 ° * Patient # 1 is a 29-year-old woman with 5, 3, and 170 pounds of rheumatoid arthritis (naive) medical history. At the first examination, the patient presented with pain, swelling, and tenderness in the joints of the fingers, wrists, toes, feet, and knees. She complained of enlightenment restrictions such as not being able to bend knees or running and having difficulty squatting. Its hematological test has a normal red blood cell deposition rate (ESR) and. Reactive egg (CRP) reading. The patient's cholesterol was 99 g / g. Its slimming use Xie in 3 00 mg i week 'LoeminFe Mm has been treated and -46 This paper size applies Chinese National Standard (CNS) A4 specifications (210X 297 meals) MW-(Please read the precautions on the back before filling (This page) 1Γ 1221772 A7

經濟部中央標準局員工消費合作社印製 服用多維生素:其診斷為帶—tis的風濕性關節炎。 母日基礎服用營養飲料補品一個月後, 和腫脹皆減低,且其腳部的疼痛和腫脹皆消失 其感覺“較不痛,,1 “感財75%更好,,。其報: 有增加的能量。其ESR和CRp # ,/…、 降低到186古古/ v人 咕值保持正常但其胆固醇值 ^ j 公合。患者持續其醫藥配合以卵為主的飲 於第二個月期間,患者感覺她的手較壞且其呈現出手指斑 腕邵有腫脹並報導其手部在晚上會麻木。她的聊感覺“較 予一 W生的i胆' 砰估為孩患者變得稍壞。其在攜帶購物 袋或打開盒子時仍會有痛感。她的職和⑽讀值保持正 吊且其胆固醇值保持在189毫克/公合。其持續服用醫藥且 依方案的時程停止產物使用。 於不同產物一個月之後,手和腳都回復腫脹和柔軟。其官 能限值保持其第一次呈現者。患者仍感覺乃% “更好些 。其E S R和C R P讀值保持正常而其胆固醇值降低到1 8 〇 毫克1公合。 關節炎徵候的評分係從患者本身對徵候的評估而定的。特 別者’患者被要求指出關節的腫脹,疼痛及/或柔軟量。根 據此種患者評估,產生顯示出徵候程度之數值。該數值範 圍從3 6的高值(最大腫脹,疼痛和柔軟量)到〇之低值 (沒有腫脹,疼痛或柔軟現象)。 從患者# 1的關節炎病況產生之評分如下: 提出時= 14 —1- - I mPrinted by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. Taking multivitamins: Its diagnosis is rheumatoid arthritis with tis. After taking nutritional beverage supplements on the mother's day for one month, the swelling and swelling were reduced, and the pain and swelling on his feet disappeared. It felt "less painful, 1" and 75% better wealth. The report: There is increased energy. Its ESR and CRp #, / ..., decreased to 186 Gugu / v. The value of Gu remained normal but its cholesterol value was ^ j. The patient continued her medication with an egg-based drink. During the second month, the patient felt her hands were bad and she showed finger spots. She had swollen wrists and reported that her hands were numb at night. Her chat feels “more ill than the one that gave birth to a child ’s life. It ’s estimated that the child is a little worse. She still feels pain when carrying shopping bags or opening the box. Her job title and reading value remain upright and her Cholesterol value remained at 189 mg / gong. It continued to take medicine and stopped using the product according to the schedule of the program. After one month of different products, hands and feet returned to swell and softness. Its functional limit kept its first appearance The patient still feels "% better". The readings of E S R and C R P remained normal while their cholesterol values decreased to 180 mg 1 mol. The score for arthritis symptoms is based on the patient's own assessment of the symptoms. In particular, the patient is asked to indicate the amount of swelling, pain, and / or softness of the joint. Based on this patient evaluation, a value showing the degree of symptoms is generated. The value ranges from a high value of 36 (maximum swelling, pain, and softness) to a low value of 0 (no swelling, pain, or softness). The score from Patient # 1's arthritis condition is as follows: At presentation = 14 —1--I m

fn f—1 g - I e先閱讀背面之注意事項再填寫本頁) I- — In i------ · 訂 47- 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 21221772 五、發明説明(45 ) 經濟部中央標準局員工消費合作社印製 食用以卵為主的飲料一個月= 食用以卵為主的飲料二個月= 停用飲料後一個月 患者# 2 /=3:位88歲的婦女5, 3,,1㈣,有風濕性關節炎 歷。她在下肢和肩部呈現出疼痛。物理檢 查揭路出手指與踩部有腫脹,疼痛和柔軟。在官能上其只 ^有限方Μ路且難以彎曲其臂。其血液學檢驗顯= 有南嫩(36愛米/小時),CRP(1.64毫克/公合)及22〇毫克 /公合之總膽固醇值。其所受治療為:氨甲蝶呤5毫克/週, Orudis KT 2天 ’ Ca 1 500 毫克,Fosomax 1〇 亳克,潑尼 松5¾克q2d(每隔一天),及服用多維生素。同樣地,嗦 者持續接受這些醫藥加上以卵為主的飲料。 μ 在起始以卵為主的飲料一個月後,她仍抱怨手腫脹,膝疼 痛,及不能腫眼。該忠者報告說有,,5〇%更好些,,,”概括 地感覺較好”及”走得更好”。其仍感痛,不過其疼痛的發作 較不頻繁。血液學結果為ESR(3〇毫米/小時)和cRp(i㈠ 笔克/公合)’且觀察到膽固醇增加到2 3 2毫克/公合。 在食用產物兩個月後,患者報告,,其感覺98 %更好些,, 不過其έ此限制仍保持相同。血液學結果顯示其e $ R有 降(2 1 *米/時)且回復到正常CRp讀值(&lt; 〇 5毫克/公合) 其總膽固醇保持為2 3 4毫克/公合。患者持續服用醫藥, 依時程,中斷以卵為主的飲料。 在停用產物一個月後患者抱怨手指和腿有嚴重關節痛 8 患 下 且 (請先閱讀背面之注意事項再填寫本頁) -·fn f—1 g-I e Please read the notes on the back before filling in this page) I- — In i ------ · Order 47- This paper size applies to China National Standard (CNS) A4 (210X 297 (Mm) 21221772 V. Description of the invention (45) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs for consumption of eggs-based beverages for one month = consumption of eggs-based beverages for two months = one month after discontinuation of beverages # 2 / = 3: 88 women, 5, 3, 1 years old, have a history of rheumatoid arthritis. She showed pain in her lower limbs and shoulders. Physical examination revealed swelling, pain, and softness of the fingers and tread. Functionally it only has a finite square path and it is difficult to bend its arms. The hematological test showed a total cholesterol value of Nannen (36 Amy / hour), CRP (1.64 mg / gong) and 22 mg / gong. His treatment was: methotrexate 5 mg / week, Orudis KT 2 days ’Ca 1 500 mg, Fosomax 10 g, prednisone 5¾ g q2d (every other day), and taking multivitamins. Similarly, people continue to receive these medicines plus egg-based beverages. μ One month after starting her egg-based drink, she still complained of swelling in her hands, pain in her knees, and inability to swell her eyes. The loyalty reported that, 50% is better, "feel better in general" and "go better". He still feels pain, but his pain is less frequent. Hematological results were ESR (30 mm / hour) and cRp (i㈠Pg / Kong) 'and an increase in cholesterol was observed to 2 3 2 mg / Kong. Two months after consuming the product, patients reported that it felt 98% better, but the limits remained the same. Hematological results showed a decrease in e $ R (21 * m / h) and returned to the normal CRp reading (&lt; 0.05 mg / kg), and its total cholesterol remained at 234 mg / kg. The patient continued to take medicine and discontinued the egg-based drink according to the schedule. One month after the product was discontinued, the patient complained of severe joint pain in the fingers and legs. 8 (and please read the precautions on the back before filling this page)-·

IT -48IT -48

本紙張尺度賴巾關家^7^7^^7 2T〇i29^F 1221772 Α7 Β7 五、發明説明(46 ) 展現出腕部腫脹。其感覺其有&quot;5〇%較壞,,。其ESr(27毫米 /小時)水平與膽固醇(2 5 7毫克/公合)關始爬升,但其 CRP(&lt;0.5毫克/公合)水平保持正常。 關節炎欲候的評分係從患者本身對徵候的評估而定的。 特別者,患者被要求指出關節的腫脹,疼病及/或柔軟量。 根據此種患者評估,產生顯示出徵候程度之數值。該數值 範圍從3 6的咼值(最大量的腫脹,疼痛和柔軟)到〇之性質 (沒有腫脹,疼病或柔軟現象)。 從患者# 2的關節炎病況產生之評分如下: 提出時= j 〇 食用以卵為主的飲料一個月=7 食用以卵為主的飲料二個月=2 停用飲料後一個月= 1〇 患者# 3 心者#3為位79歲男人51 〇,,152镑,有骨關節炎和動 脈粥樣硬化性心肌病之病歷。其徵候為下背部,肩部,膝 和腳的疼痛。其醫藥治療包括:NitrQderm貼片,叫〇譲 0.125,阿斯匹靈80耄克和以…以2〇毫克。官能限制 經濟部中央標準局員工消費合作社印製 (請先聞讀背面之注意事項再填寫本頁) 、-口 為:難以移動手臂及衰竭。血液學結果為正常的ESR和 C R P且膽固醇讀值為2丨7毫克/公合。 在飲用#產物-個月加上前述醫藥治療_個月,患者感 覺”稍好些(1〇·2。%)”。他仍報告右側和左側肩痛,且報告 他不能站立且其右膝膨脹。官能限制保持如前所報告者。 其ESR和CRP讀值皆正常且其膽固醇水平為副毫克/公 -49- 1221772 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(47 ) Ο 在食用產物兩個月之後,患者持續感覺”稍好些,,。徵候 包括右膝疼痛及走路困。膽固醇難讀值未取得但E s R和 CRP保持在正常水平。 於不用產物一個月後,患者整體感覺稍好些但比前個月 稍壞。徵候包括右腿腫脹,肩痛及下背部疼痛。關節評估 指出肩部和下背部疼痛。官能限制為難以移動手臂及感到,, 衰竭’’。ESR和CUP讀值皆正常且膽固醇保持在18〇毫克/公 合。 關節炎徵候的評分係從患者本身對徵候的評估而定的。 特別者,患者被要求指出關節的腫脹,疼痛及/或柔軟量。 根據此種患者評估,產生顯示出徵候程度之數值。該數值 $已圍從3 6的咼值(最大量的腫脹,疼痛和柔軟)到〇之低值 (沒有腫脹,疼痛或柔軟現象)。 從患者# 3的關節炎病況產生之評分如下: 提出時= 11.5 食用以卵為主的飲料一個月=2 食用以卵為主的飲料二個月=3 停用飲料後一個月= 8 5 其^的病歷顯示有類似的改良且證實本發明在消除關節 炎性關節的疼痛和發炎上之效用而無副作用。 本發明已經由特別參照其某些軟佳實施例而說明過,但 要了解者某些變更和修改可在上述及後附申請專利範圍中 所足義之本發明旨意與範圍内完成。 -50- 本紙浪尺麟财關家縣(CN7TA4^( 210X297^ 蜷—丨 (請先閱讀背面之注意事項再填寫本頁} -訂 1221772 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(48 ) 實例9 唾液酸分浙 唾液酸釋出,純化,和分析之流程圖This paper scale Lai Jin Guanjia ^ 7 ^ 7 ^^ 7 2T〇i29 ^ F 1221772 Α7 Β7 V. Description of the invention (46) Shows swelling of the wrist. It feels that it is &quot; 50% worse. Its ESr (27 mm / hr) level climbed with cholesterol (275 mg / kg), but its CRP (&lt; 0.5 mg / kg) level remained normal. The score for arthritis symptoms is based on the patient's own assessment of the symptoms. In particular, patients are asked to indicate swelling, pain and / or softness of the joints. Based on this patient evaluation, a value showing the degree of symptoms is produced. The value ranges from a threshold value of 36 (the maximum amount of swelling, pain, and softness) to a property of 0 (no swelling, pain, or softness). The score from Patient # 2's arthritis condition is as follows: At presentation = j 〇 One month of consumption of egg-based beverages = 7 Two months of consumption of egg-based beverages = 2 One month after withdrawal of beverages = 1〇 Patient # 3 心 者 # 3 is a 79-year-old man with 51,152 pounds and has a history of osteoarthritis and atherosclerotic cardiomyopathy. The symptoms are pain in the lower back, shoulders, knees and feet. Its medical treatments include: NitrQderm patch, called 譲 0.125, aspirin 80 耄 g and ... to 20 mg. Functional restrictions Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page),-Mouth: It is difficult to move the arm and exhaustion. Hematological results were normal ESR and C R P and cholesterol readings were 2 mg / g. At Drinking # Product-month plus the aforementioned medical treatment_month, the patient felt "slightly better (10.2%)". He still reports right and left shoulder pain and reports that he cannot stand and his right knee is inflated. Functional restrictions remain as reported previously. Its ESR and CRP readings were normal and its cholesterol level was decigrams / mg-49-1221772 A7 B7. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (47) 〇 Two months after eating the product, the patient “Sustained feeling” is slightly better. Symptoms include pain in the right knee and difficulty walking. Cholesterol hard-to-read values were not obtained but E s R and CRP remained at normal levels. After one month without using the product, the patient overall felt slightly better but better than the previous one. Months are slightly worse. Symptoms include swelling of the right leg, shoulder pain, and lower back pain. Joint evaluation indicates pain in the shoulder and lower back. Functional limitation is difficulty in moving arms and feeling, failure, ”ESR and CUP readings are normal and cholesterol Maintained at 18 mg / gong. The score for arthritis symptoms is based on the patient's own assessment of the symptoms. In particular, patients are asked to indicate the amount of swelling, pain and / or softness of the joints. Based on such patient evaluation, A numerical value showing the degree of symptoms is generated. The value $ has ranged from a threshold value of 36 (the maximum amount of swelling, pain, and softness) to a low value of 0 (no swelling, pain, or softness). The score from the arthritis condition of patient # 3 is as follows: At the time of presentation = 11.5 Consumption of egg-based beverages for one month = 2 Consumption of egg-based beverages for two months = 3 One month after discontinuation of beverages = 8 5 Its medical records show similar improvements and confirm the effectiveness of the present invention in eliminating pain and inflammation of arthritic joints without side effects. The present invention has been described with particular reference to certain soft examples, but Some changes and modifications of the reader can be completed within the meaning and scope of the present invention which is sufficient in the scope of the above-mentioned and attached patent applications. -50- This paper Langchi Lincai Guanjia County (CN7TA4 ^ (210X297 ^ 蜷 — 丨 (Please Read the precautions on the back before filling out this page}-Order 1221772 A7 B7 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of Invention (48) Example 9 Sialic acid release, purification, and analysis of sialic acid Figure

唾液酸從糖蛋白的釋出與純化 於相當低0 -乙醯基損失下的唾液酸釋出係用1毫升2M乙 酸在密封,有皺縮頂部的管瓶内於8 〇它下3小時而達成者。 加入KDN作為水解前的内標準。 在酸水解之後,將反應混合物冷卻並將管瓶離心以脫除 任何不溶物。將上澄液轉移到一微型5毫升), Centric〇n(2 毫升),或 Centriplus(15 毫升)1〇,〇〇〇 分子量 截止率離心裝置内。經由真空離心脫除濾液中的乙酸並將 樣口σ再 &gt;答於〇 . 5當升水。 將樣品施加到1毫升Dowex 50AG1 X 8(氫形式)/水管栓 上以脫除陽離性雜質。將流經液及4 - 5毫升水洗液收集在裝 有4 0升1 Μ甲酸的薄壁離心管内。將酸化洗液宜空離心乾以 脫除掉管柱所產生的弱酸。The release and purification of sialic acid from glycoproteins is at a relatively low level of 0-acetamidine. The sialic acid release is sealed with 1 ml of 2M acetic acid in a vial with a crimped top at 80 ° C for 3 hours. Achieved. KDN was added as an internal standard before hydrolysis. After acid hydrolysis, the reaction mixture was cooled and the vial was centrifuged to remove any insolubles. Transfer the supernatant to a mini 5 ml), Centricon (2 ml), or Centriplus (15 ml) 10,000 molecular weight cutoff centrifuge device. The acetic acid was removed from the filtrate by vacuum centrifugation and the sample port σ was replied to 0.5 liter of water. Samples were applied to 1 ml of Dowex 50AG1 X 8 (hydrogen form) / water pipe plug to remove cationic impurities. Collect the flow-through and 4-5 ml of water washing solution in a thin-walled centrifuge tube containing 40 liters of 1 M formic acid. The acidified wash solution should be centrifuged to dryness to remove the weak acid produced by the column.

將樣品再溶於0.5毫升1 0 m Μ甲酸鈉,ρ Η 5.5 0中並施加 到1毫升經10 mM甲酸鈉pH 5.50缓衝的Dowex AG 3 X 4(曱酸根形式)弱陰離子交換樹脂上。立即用5毫升1〇 mM -51 - 本纸張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) ---------Φ |丨 (請先閱讀背面之注意事項再填寫本頁) 訂 1221772 經濟部中央標準局員工消費合作社印製 A7 -- —---—— __ _B7 五、發明説明(49 ) 甲杈洗提官柱。丟棄流經液洗液。用1 0毫升1 Μ甲酸將„垂 :酸洗提到薄壁離心管内並將洗提液乾燥後再懸浮於水 註:本程序中的所有步驟,絲存總〇乙醯基為唯-考慮 時’可在室溫下實施。若需要防止〇·乙耗移走時,則戶^ 有步驟必須在rc下用i Μ乙酸峨咬缓衝液,ρΗ 5 5取代夏 Μ甲敗而後貫施。 管柱說明The sample was re-dissolved in 0.5 ml of 10 μM sodium formate, pH Η 5.50 and applied to 1 ml of Dowex AG 3 X 4 (phosphonate form) weak anion exchange resin buffered with 10 mM sodium formate pH 5.50. Immediately use 5 ml of 10mM -51-This paper size applies to China National Standard (CNS) A4 (21 OX 297 mm) --------- Φ | 丨 (Please read the precautions on the back first (Fill in this page again) Order 1217772 Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 ---------- __ _B7 V. Description of the Invention (49) A branch of elution. Discard the flow-through lotion. Use 10 ml of 1 M formic acid to draw the "dip: acid wash into a thin-walled centrifuge tube and dry the eluent before resuspending in water. Note: For all steps in this procedure, the total amount of ethyl acetate is only-consider Shi 'can be carried out at room temperature. If it is necessary to prevent the removal of β-consumption, the user must use i M acetate acetate buffer at rc, ρΗ 5 5 to replace Xia M for subsequent application. Column description

Dowex 50 AG 1X8,氫形式:將2毫升樹脂以匙取到—小 的,可棄置式塑膠燒結管柱内。管柱經先加入5毫升丨Μ H C1後用5耄升液份的水洗提到ρ Η上升到_4以上。Dowex 50 AG 1X8, hydrogen form: Take 2 milliliters of resin with a spoon—small, disposable plastic sintered tubing. The column was firstly charged with 5 ml of MH C1, and then washed with 5 liters of water to mention that ρ Η rose above _4.

Dowes AG 3Χ4(或4Χ4),甲酸根形式:將丨毫升樹脂以 匙取到-小的可丟棄式塑膠燒結管柱内,且經由用 M NaOH洗管柱而轉化成氫氧離子形式。㈣用3_5毫升! Μ甲酸洗管柱或直到流出液pH值為_ i 5為止而將氫氧離子 形式轉化為甲酸根形式。用去離子水洗管柱。然後用1〇 m Μ甲酸鋼’ p Η 5 · 5緩衝該管柱。 以 Di〇nex HPAEC/PAD 在 Carb〇pac ρΑ_ι〇 管柱上分析唾 液酸 用Dlonex GP40梯度泵,ED4〇電化學偵檢器和 CarboPac 1&gt;八-10保護管柱與分析管柱以HpAEc/pAD分 析唾液酸樣品。樣品注射係用AS 3 5〇〇自動取樣器進行 的。使用 1〇〇 mM Na0H(洗提劑 〇和1〇〇 mM Na〇H, 1M NaAc(洗提劑D)以梯度法洗提唾液酸。此方法所用的 -52- 本紙張尺度適用中國國家標準(CNS ) A4規格( 4! Γ靖先閑讀背面之注意事頊再填寫本頁」 -T 二-ά 1221772 A7 五、發明説明(5〇 ) 分離梯度為: 時間(分)A% B% C% D% INJECT TITL1 起始 一 一 93.0 7.0 0 — - 93.0 7.0 X X 10 - 一 70.0 30.0 11 - 一 70.0 30.0 12 一 一 93.0 7.0 27 一 一 93.0 7.0 f n n 0H an ffi n ft— I -n (請先閲讀背面之注意事項存填寫本頁) 經濟部中央標準局員工消費合作社印製 此方法以1毫升/分的流速而需要2 7分鐘。唾液酸係經由 使用KDN作為内標準而定量分析出。將樣品譜皋面積歸一 化以调整因水解或因離子交換清理所致KDN信號損失。 結論 分的唾液酸分析 -----~一 卵部份物 自由+結合唾液酸 __含量/克卵_ %唾液酸 食用卵卵黃 1.9毫克 __________ .19% _ 食用卵卵白 1毫克 .10% 一 PL-100卵黃的3k部价物 7.7毫克 .77% _ PL-100卵白的3k部份铷 0.75毫克 .075% ^ 上表顯不出用Standard Dion ex方案和PAD偵檢分析卵 所含諸部份物中的自由與結合型唾液酸含量。此程序配合 Dowex樹脂的預備清除而實施,導致全量回收及消除掉層 析1晋上的其它雜質譜秦。 .參! -53- 本纸張尺度適财關家^ v 名 7 11 2 12 A7 B7 五、發明説明(51 ) 卵黃所含3 k部份物的分離不會顯著地增環結合型和自由 唾液酸之含量。 卵黃3 k部份物在老鼠第II型膠原檢定中的生物活性不能 歸因於唾液酸含量因其含量非常低(2.7毫克/劑量)之故。 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央橾準局員工消費合作社印製 -54- 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) j* &gt; 1-, \ - -- | 1 修正 申請曰期 86.09.08 案 號 086112945 類 別 隱1Κ — (以上各欄由本局填註) A4 C4 中文說明書替換頁(93年1月) 雲還專利説明書1221772 中 文 部份純化形式之雞卵抗發炎組合物 —、發明 新型 名稱 英 文Dowes AG 3 × 4 (or 4 × 4), formate: Take 1 ml of resin with a spoon into a small disposable plastic sintered tubing column, and convert it to hydroxide ion form by washing the column with M NaOH. ㈣ Use 3_5 ml! M formic acid washes the column or until the pH of the effluent is _ i 5 to convert the hydroxide ion form to the formate form. Wash the column with deionized water. The column was then buffered with 10 m of formic acid steel 'pΗ5 · 5. Dialex HPAEC / PAD was used to analyze sialic acid on Carbopac ρΑιιιη column with Dlonex GP40 gradient pump, ED40 electrochemical detector and CarboPac 1> 8-10 protection column and analysis column with HpAEc / pAD Analysis of sialic acid samples. Sample injection was performed using an AS 3500 autosampler. 100 mM NaOH (eluent 0 and 100 mM NaOH, 1M NaAc (eluent D)) was used to elute sialic acid in a gradient method. -52- used in this method This paper standard applies to Chinese national standards (CNS) A4 specifications (4! Γ Jing first read the notes on the back and then fill out this page "-T 二 -ά 1221772 A7 V. Description of the invention (50) The separation gradient is: time (minutes) A% B% C% D% INJECT TITL1 Start-93.0 7.0 0--93.0 7.0 XX 10--70.0 30.0 11--70.0 30.0 12-93.0 7.0 27-93.0 7.0 fnn 0H an ffi n ft— I -n (Please Please read the notes on the back and fill in this page.) This method is printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs at a flow rate of 1 ml / min and takes 27 minutes. Sialic acid is quantitatively analyzed by using KDN as the internal standard. The area of the sample spectrum was normalized to adjust the loss of KDN signal due to hydrolysis or ion exchange cleaning. Conclusion Analysis of sialic acid ----- ~ free egg component + bound sialic acid __ content / g Egg _% sialic acid yolk yolk 1.9 mg __________. 19% _ edible egg 1 mg. 10% 3k part of PL-100 egg yolk 7.7 mg. 77% _ PL-100 egg white 3k part 铷 0.75 mg. 075% ^ The above table does not show the use of Standard Dion ex protocol and PAD detection Analyze the free and bound sialic acid content of the eggs. This procedure is implemented in conjunction with the preliminary removal of Dowex resin, which results in the full recovery and elimination of other impurities in the chromatography 1. See!- 53- This paper is suitable for financial management. V Name 7 11 2 12 A7 B7 V. Description of the invention (51) The separation of the 3 k parts contained in the egg yolk will not significantly increase the content of ring-bound and free sialic acid The biological activity of yolk 3K in rat type II collagen test cannot be attributed to the sialic acid content due to its very low content (2.7 mg / dose). (Please read the precautions on the back before filling out this Page) Printed by the Consumer Cooperatives of the Central Bureau of Standards and Quarantine of the Ministry of Economic Affairs-54- This paper size applies to the Chinese National Standard (CNS) A4 (210X297 mm) j * &gt; 1-, \--| 1 Issue 86.09.08 Case No. 086112945 Category Hidden 1KK — (The above columns are to be filled by this Office ) A4 C4 Chinese manual replacement sheets (93 January) Cloud patent specification further portion of the purified form of chicken eggs 1,221,772 described anti-inflammatory compositions -, English name of the new invention

CHICKEN EGG ANTI-INFLAMMATORY COMPOSITION IN PARTIALLY PURIFIED FORM 姓 名 國 籍 1·珊德拉G·費茲派翠克-麥利高特 2·傑夫瑞G·亨察 3. 洋-宙李 4. 李R.貝克 人 住、居所 姓 名 (名稱) 國 籍 1.2.4.美國 3.加拿大 1.导國賓州羅斯瓦利市長角巷27號 2· _國賓州西契斯特市柯拜路922號 3. _國俄亥俄州辛辛那提市溫洛普路9〇43號 4·美國俄亥俄州理巴諾市北自由-庫特路167〇號 美商DCV生物公司 美國 三、申請人 住、居所 (事務所) 代表人 姓 名 O:\49\49495-4 美國德拉瓦州威靈頓市希維爾赛得路3521號 歐瑞愛達斯泰森CHICKEN EGG ANTI-INFLAMMATORY COMPOSITION IN PARTIALLY PURIFIED FORM Name Nationality 1. Sandra G. Fitzpatrick-Merritte 2. Jeffrey G. Hencha 3. Yang-Zhou Li 4. Lee R. Baker Name of residence and residence (name) Nationality 1.2.4. United States 3. Canada 1. Guiding State, 27 Changjiao Lane, Rose Valley City, Pennsylvania 2 _ 922 Coby Road, West Chester, State of Pennsylvania 3. _ State Ohio No. 9043 Wenlop Road, Cincinnati, USA 4. DCV Bio Inc., No. 1670 North Liberty-Kut Road, Ribano, Ohio, U.S. III. Applicant's Residence, Residence (Office) Name of Representative O : \ 49 \ 49495-4 Oriidas Tyson, 3521 Seaville Road, Wellington, Delaware, USA

930120.D〇aTSP 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公董)930120.D〇aTSP This paper size is applicable to China National Standard (CNS) A4 specification (210X297 public director)

Claims (1)

月 4 年 3 案(9 請本 申換利聲 專圍 號範 六、申請專利範圍 A B c DCase 4 of 3 years (9, please apply for this application for Lisheng special range No. 6. Scope of patent application A B c D L 一種經部份純化形式的抗發炎組合物,其中該抗發炎組 合物包括下列特性: a) 其係存在於雞所產卵的全卵及卵黃之中; b) 其為超免疫卵之水滲性、去脂部份,其分子量大小低 於3,0 0 〇道耳頓; c) 其具熱安定性; d) 具有口服活性;及 e) 可抗拒消化性酵素的降解作用; 其中該組合物可由非經腸、皮下、靜脈内、肌肉内、腹 膜内、鼻内、口服或局部施用;及 其中该組合物係經下述方法部份純化過者: a)將全卵或卵黃脫脂; b )從經脫脂的全卵或卵黃分離出水溶性部份物; c) 從該水溶性部份物分離出低於約3 〇 〇 〇道耳頓的通透 物;及 d) 將該低於約3 0 0 〇道耳頓的通透物分部分離以回收該經 部份純化的抗發炎組合物。 2. 根據申請專利範圍第1項之抗發炎組合物,其中該雞係 經用免疫原予以超免疫化。 3. 根據申凊專利範圍第2項之抗發炎組合物,其中該免疫 原疫苗包括細菌抗原。 〇:\4«;\49495-4-93()409 DOQTSP 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)L An anti-inflammatory composition in a partially purified form, wherein the anti-inflammatory composition includes the following characteristics: a) it is present in whole eggs and yolks of eggs laid by chickens; b) it is water of hyperimmune eggs Osmotic and fat-removing fraction, its molecular weight is less than 3,000 Daltons; c) it has thermal stability; d) it has oral activity; and e) it can resist the degradation of digestive enzymes; The composition may be administered parenterally, subcutaneously, intravenously, intramuscularly, intraperitoneally, intranasally, orally or topically; and wherein the composition is partially purified by the following methods: a) degreasing whole eggs or yolk B) separating water-soluble fractions from defatted whole eggs or yolks; c) separating permeates below about 3,000 Daltons from the water-soluble fractions; and d) reducing the low The permeate fraction was separated at approximately 3,000 Daltons to recover the partially purified anti-inflammatory composition. 2. The anti-inflammatory composition according to item 1 of the application, wherein the chicken is hyperimmune with an immunogen. 3. The anti-inflammatory composition according to item 2 of the patent claim, wherein the immunogen vaccine includes a bacterial antigen. 〇: \ 4 «; \ 49495-4-93 () 409 DOQTSP This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)
TW86112945A 1997-03-10 1997-09-08 Chicken egg anti-inflammatory composition in partially purified form TWI221772B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81418797A 1997-03-10 1997-03-10

Publications (1)

Publication Number Publication Date
TWI221772B true TWI221772B (en) 2004-10-11

Family

ID=34435951

Family Applications (1)

Application Number Title Priority Date Filing Date
TW86112945A TWI221772B (en) 1997-03-10 1997-09-08 Chicken egg anti-inflammatory composition in partially purified form

Country Status (1)

Country Link
TW (1) TWI221772B (en)

Similar Documents

Publication Publication Date Title
DK166905B1 (en) MEDICINE USED FOR PASSIVE HETEROLOGICAL IMMUNIZATION OF A MAMMAL
RU2580299C2 (en) Streptococcus pneumoniae vaccines and compositions
Jertborn et al. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1O139 whole cell cholera vaccine
JP2002501526A (en) Method for producing immunoglobulin A in milk
JPH10500958A (en) Treatment and prevention of Helicobacter infections
CA2249448C (en) Egg anti-inflammatory composition, method of isolation and use
Isfahani et al. The effect of capsulated and noncapsulated egg-yolk–specific antibody to reduce colonization in the intestine of Salmonella enterica ssp. enterica serovar Infantis–challenged broiler chickens
US20020044942A1 (en) Transfer factor composition and process for producing same
JP4554728B2 (en) Pharmaceutical or food composition for the treatment of a medical condition associated with graft rejection or allergy or autoimmune reaction
WO1999036077A1 (en) Composition and method for treatment and prevention of arthritis and/or autoimmune diseases
US6803035B2 (en) Anti-diarrheal and method for using the same
CN113181349B (en) M cell-targeted multi-epitope oral vaccine and application thereof in hydatid vaccine
Abushahba et al. Safe subunit green vaccines confer robust immunity and protection against mucosal Brucella infection in mice
AU767570B2 (en) Egg anti-inflammatory composition and method of treating and preventing inflammation
TWI221772B (en) Chicken egg anti-inflammatory composition in partially purified form
JP5047431B2 (en) Glucosamine and eggs reduce inflammation
CN114073766A (en) Helicobacter pylori epitope peptide and application thereof
AU772785B2 (en) Anti-diarrheal and method for using the same
Abushahba et al. Safe subunit green vaccines confer robust immunity and protection against mucosal Brucella infection in mice. Vaccines. 2023; 11: 546
RU2683027C2 (en) Polyvalent combined immunizing and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, method for production of this preparation, its use and vaccine comprising this preparation
JP4911894B2 (en) Composition for oral administration for preventing rheumatoid arthritis
Portnyagina et al. Immunochemical characteristics of synthetic peptides with T-cellular and B-cellular epitopes of nonspecific porins of pathogenic Yersinia
CN104587458B (en) The Bivalent DNA Vaccine of prevention giardiasis and enteric coated preparation thereof
Duff The Use of Antibody-Guided and Recombinant Subunit Vaccine Technology in the Study and Control of Enteric Health in Poultry
MXPA00007005A (en) Composition and method for treatment and prevention of arthritis and/or autoimmune diseases

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees